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ÑV Jl×Rp T¥Ym 
UúX¬Vô LônfNp A±Ï±Ls Es[ ÏZkûRLÞdÏ G°Rp 
LiÓ©¥dLd á¥V CWjR úNôRû] Øû\ Tt± BWônRp 
 
BWônf£ ¨ûXVm  :  ÏZkûRLs NêL SX UÚjÕYl©¬Ü 
 AWÑ vPôu- UÚjÕYUû], 
 ùNuû] - 600 001. 
TeÏ ùTßm úSôVô°«u ùTVo :     YVÕ 
TeÏ ùTßm úSôVô°«u Gi :     Tô-]m: Bi    ùTi 
úSôVô°«u ®XôNm : 
 
 
úSôVô° CRû] ( ) Ï±dLÜm : 
 
 
 úUúX Ï±l©hÓs[ UÚjÕY Bn®u ®YWeLs G]dÏ 
®[dLlThPÕ. GuàûPV NkúRLeLû[ úLhLÜm, ARtLô] RÏkR 
®[dLeLû[ ùT\Üm YônlT°dLlThPÕ. 
 Sôu Gu ÏZkûRûV Ru²fûNVôLRôu TeúLtL 
AàU§d¡ú\u. GkR LôWQj§]ôúXô GkR LhPj§Ûm GkR NhP 
£dLÛdÏm EhTPôUp Gu ÏZkûRûV CqYôn®p CÚkÕ ®Xd¡d 
ùLôs[Xôm Guß A±kÕ ùLôiúPu. 
 CkR BnÜ NmTkRUôLÜm úUÛm CûR NôokR BnÜ 
úUtùLôsÞm úTôÕm CkR Bn®p TeÏùTßm UÚjÕYo Gu 
ÏZkûR«u UÚjÕY A±dûLLû[ TôolTRtÏ Gu AàU§ 
úRûY«pûX G] A±kÕ ùLôs¡ú\u. Gu ÏZkûRûV Bn®p 
CÚkÕ ®X¡d ùLôiPôÛm CÕ ùTôÚkÕm G] A±¡ú\u. 
 CkR Bn®u êXm ¡ûPdÏm RLYpLû[Ùm, T¬úNôRû] 
Ø¥ÜLû[Ùm Utßm £¡fûN ùRôPoTô] RLYpLû[Ùm UÚjÕYo 
úUtùLôsÞm Bn®p TVuTÓj§d ùLôs[Üm AûR ©WÑ¬dLÜm 
Gu ØÝ U]ÕPu NmU§d¡ú\u. 
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BnûY úUtùLôsÞm UÚjÕY A¦dÏ EiûUÙPu CÚlúTu 
Gußm Eß§ A°d¡ú\u. Gu ÏZkûR«u EPp SXm 
Tô§dLlThPôúXô ApXÕ G§oTôWôR YZdLj§tÏ Uô\ô] úSôndÏ± 
ùRuThPôúXô EPú] ARû] UÚjÕY A¦dÏ ùR¬®lúTu G] 
Eß§ A°d¡ú\u. 
 CkR Bn®p Gu ÏZkûRdÏ CWjRm, £ß¿o, GdvúW, 
vúLu EhTP Aû]jÕ T¬úNôRû]Lû[Ùm ùNnÕ ùLôs[ Sôu 
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ùNnÕ, T¬úNôRû]«u T-]ûUûV LiP±Rp ARu êXm ®Vô§ûV 
N¬ ETôL ®ûW®p LiÓ©¥jR 
BnÜ SûPØû\Ls : 
£¡fûN A°lTRtÏ HtTôÓ ùNnRp CqYôWônf£«u úSôdLUôÏm. 
EsúSôVô°L[ôL ApXÕ ùY° úSôVô°VôL Es[ UúX¬V LônfNp 
A±Ï±Ls Es[ ÏZkûRLs CkR BWônf£«p úNojÕd 
ùLôs[lTÓYôoLs. 
AkRWeL RuûU : 
EeLs ÏZkûR«u UÚjÕY T§úYÓLs ªLÜm AkRWeLUôL 
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ùY°«ÓYRu êXm úSôVô°«u AûPVô[m LôhPlTP UôhPôoLs. 
Bn®p EeLs TeúLt× Utßm EeLs E¬ûULs : 
CkR Bn®p EeLs ÏZkûRL°u TeúLt× ØÝYÕm 
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INTRODUCTION 
Malaria  is  an  infection  caused  by  parasite  of Plasmodium 
species. It is prevalent over hundred countries across the globe. More 
than 1.6 billion people are exposed or at risk of infection throughout  the  
world. 
The prevalence of this infection is maximum in Africa, Asia, South 
America. These areas are in the tropical zones hence an ideal place for 
breeding of mosquitoes. The temperature, humidity, rainfall all favours 
the multiplication of mosquitoes and simultaneously the species causing 
malaria. 
Since India falls in the tropical zones, our country also forms the 
endemic home of malaria. Myanmar, Bangladesh, India, Indonesia
3
 
account for large number of cases in Southeast Asia. 
The dominant species in India is the Plasmodium vivax, next is 
Plasmodium falciparum
4
. The latter is the most fatal of the four species 
infecting man. The mortality is mainly encountered in young children and 
pregnant women who are vulnerable to the complications of malaria, due 
to the lowering of acquired immunity. 
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In the setting of low prevalence and low resistance zones, erratic 
use of antimalarials
6
 causes the disease symptoms but there is no parasite 
clearance.  
The parasite gains resistance to drugs and symptoms recur. The 
physician thinks  it is a fresh infection and treats. The resistant parasite is 
now transferred to the other patients. This cycle ensures conversion of 
zone of high incidence and mortality. 
Hence, cure is defined as complete elimination of the parasite from 
the  host. Treating non-malarial cases with antimalarial drugs or irregular 
intake and premature stoppage of drugs before parasite clears in the 
peripheral blood contributes to drug resistance and aggravation of the 
problem and spread. Malarial card test is accurate, reliable and does not 
require skilled personal or equipment
7
. Hence it forms an excellent bridge 
for the diagnosis of  malaria in resource constrained rural setting.
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REVIEW   OF   LITERATURE 
The tropical countries cater the most number of cases of malaria, 
and it forms the most important infections causing mortality in this 
locality. Among the four species causing human infection Plasmodium 
falciparum is the leader in the race in terms of morbidity and mortality. 
    The HRP 2/PLDH test detects antigens in the blood of malaria 
patients with a minimum of 5 µL of blood. The test is simple and 
effective, able to detect the parasite in a minimum period of 10 to 15 
minutes. India is a country which caters two species of malaria 
Plasmodium falciparum and Plasmodium vivax. 
    Palmer et al studied the number of cases positive by rapid 
diagnostic test and the peripheral blood smear and found 45% and 48% 
respectively. The sensitivity of rapid diagnostic test for Plasmodium 
falciparum was 88% and specificity 99%, as far as vivax is concerned 
sensitivity 94% specificity hundred percent 
    Jelinek et al found peripheral blood smear positive by 29.8% and 
HRP2/PLDH by 24.2%. The sensitivity of Jelinek et al 88.5% 99.4% for 
Plasmodium falciparum under for vivax 61.5% and hundred percent. The 
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positive predictive value and negative predictive value for vivax and 
falciparum was around 98% – 100%. 
    Chayani N et al showed positivity of peripheral blood smear and 
HRP2/PLDH to be 52.5%, 50.8%. This study identified that the rapid 
diagnostic test have a sensitivity and specificity of 92%-100% for 
Plasmodium vivax and Plasmodium falciparum. Similar results were 
observed in other studies done by Jamshed Iqbal et al, in the year 2003 
and 2002. 
     The positive predictive value, the negative predictive value, the 
sensitivity, the specificity are determined the diagnostic power of the test. 
The above studies demonstrate that the rapid diagnostic test which detects 
antigen in the blood of patients with malaria are highly sensitive, specific, 
having a positive predictive value of 88% – 98% in case of Plasmodium 
falciparum. The about test done for Plasmodium vivax was around 
hundred percent positive predictive value to 99% negative predictive 
value. All the above tests were compared with the gold standard in the 
diagnosis of malaria the peripheral blood smear. 
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HISTORY 
              The word  "MALARIA" is derived from the word   MAL 
meaning BAD, ARIA-meaning AIR, and the word meaning  BAD AIR of 
the swamp
8
. This terminology for malaria was coined in the 17th century. 
Fifth century BC: – Hippocrates used the words tertian, quartan, to 
describe the fever of malaria based upon its periodicity. 
1600  :-the bark of cinchona was found to cure the disease in peru 
in South America next time. 
1880  :-Charles identified the protozoa present in the blood sample 
of a patient with malaria. 
1691 :-Erythrocytic phase of the parasite was accurately stained by 
Ramanosky
8
. 
1897 :-William McCullum documented that the malarial parasite 
had a sexual cycle. 
1898 :-Ronald Ross identified malaria in the birds who were beaten 
by the mosquito
8
. The avian malaria was identified. 
1948: Pre– erythrocytic stage present in the man was identified by 
Bray&shoff. 
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EPIDEMIOLOGY 
        There are  300 – 500 million cases affected by the disease per year.   
About 1 million death is encountered
1
.   The most important reason for 
the death is the delay in the diagnosis, the delay in institution of therapy.   
Both the above factors can be drastically reduced if appropriate measures 
are undertaken appropriate times. 
AGENT  
The position of the malarial parasite in the taxonomical 
nomenclature is.                    
                     Kingdom  –  Animalia. 
                     Phylum  –  protozoal. 
                     Class  –  Sporozoa. 
                     Order  –  Eucoccida. 
                     Family  –  Plasmodia. 
                     Genera  –  Plasmodium 
                     Species  –  falciparum, vivax, ovale, malaria etc... 
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Of the several species of malarial parasite the two most important 
seen in India are 
                           1 ) Plasmodium vivax – 70% 
                           2) Plasmodium falciparum – 25% 
Both the species account for about 95% of the infection due to 
malaria caused in India
10
. The other two plasmodia of human importance 
are: 
                               1) Plasmodium ovale 
                               2) Plasmodium malariae. 
ROUTES   OF  TRANSMISSION: 
            1)  The parasite lodge in the salivary gland of the female 
Anopheles mosquito, during the blood meal the parasite is injected into 
the human host. The mosquito then sucks the blood from the human 
body. 
           2) Injection of contaminated blood through blood transfusion, 
using the same needle in drug addicts form a rare source of malarial 
infection to man. This mode of transmission attains minimal importance. 
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FEMALE  ANOPHELES  MOSQUITO 
The name Anopheles is derived from the Greek word  ANO-
meaning not,  pheles – meaning profit. Put together the word meaning of 
Anopheles is 'useless '. 
          The Anopheles mosquito act as a vector of   1) malaria 
                                                                                      2) filaria 
                                                                                      3) some viruses. 
The important behaviour of mosquitoes that make them effective 
vectors
11
 of man are their  anthrophilic nature, they feed on human or 
cattle blood for the development of the malarial eggs in the stomach of 
the female anopheles mosquito. This character of the mosquitoes make 
them effective vectors for the transmission of malaria. 
The extrinsic incubation period of malarial parasite is about 10 to 
21 days. Any malarial parasite which can survive a period less than this 
does not become an effective vector for malaria. 
Genetically modified mosquito when the multiplication of malarial 
parasite inside the gut of the mosquito. The most the important vectors in 
India for transmission of malarial infection are, 
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                   1)    Anopheles culicifacies – rural areas 
                  2)     Anopheles stephensi – urban areas. 
Entomological inoculation rate or the number of  bites sustained by 
individual per day determines the transmission rate
12
. This factor depends 
upon the mosquito density, temperature, population growth and 
migration, drug and parasite resistance, lastly the deterioration of health 
care services. 
ENDEMIC: – EN (in); DEMOS (population) 
A disease or condition regularly found among the particular people 
or certain area is known as an endemic disease. 
EPI DEMIC: – EPI (upon); DEM OS (population) 
Widespread occurrence of an infection or disease more than the 
expected occurrence at the time is known as epidemic. 
TRANSMISSION  OF  MALARIA: 
The transmission of malaria depends upon three variables, they can 
be the host – human being,   the agent – the mosquito,  the environment – 
the climatic conditions. 
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1)  THE  CLIMATE:  
The temperature between 16 to 33°C provide the ideal environment 
for the transmission of malaria.   The altitude
11
 of  greater  than   2000 m 
does not favour malaria transmission. 
Permanent shallow sunlit pools of water with the perimeter of 
greater than 10 m,  with the absence of surface run-off,  the base formed 
by Clay which can hold water forms an ideal place for breeding of the 
vectors of malaria. 
The relative humidity present in the tropical countries is 
appropriate for the breeding of mosquitoes here. India being among the 
tropical countries forms and endemic home of malaria. 
 THE  AGENT: 
The Plasmodium as a complex life cycle in humans. This enables 
them to live and survive in different human cellular environment makes 
them resistant to elimination. 
The malarial parasite escapes the host immune system by 
exhibiting antigenic diversity as well as several other immunomodulatory 
functions. 
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THE  HUMAN  FACTORS: 
Human factors play an important role in the transmission of 
malaria in the regional as well as international arena, the factors 
favouring transmission of as follows: 
1) human migration – spreads infection from one place to another, 
from one geographical area to another making it a worldwide disease.  
2) social economic status – people living  low social economic 
status are prone for malarial infection since the entomological inoculation 
rate for this group of population is highly. They lack effective shielding 
from mosquitoes due to lack of pukka houses, sanitation, nets  etc. 
3) immune status of the individual – persons living in endemic 
areas have high level of immunity protecting them from infection. 
EPIDEMIOLOGICAL  INDICES  OF  MALARIA 
1. Pre-eradication  era 
a)   spleen rate: – estimates the burden of malaria transmission in  
b) parasite rate: – this is used along with spleen rate 
c) parasite density index: – index of degree of parasitaemia. 
12 
 
d) infant parasite rate: – very sensitive for malaria transmission10. 
e) average spleen rate. 
2.  Eradication era 
a) API – annual parasite index: – incidence indicator 
Total number of confirmed cases in a year/population    multiplied 
by thousand. 
 b) ABER – annual blood examination rate: index of operational 
efficiency. 
 ie =     Total number of slides seen/population under surveillance 
multiplied by thousand. 
 THE  MOSQUITO: 
By mutual adaptation between Anopheles and the Culex mosquito, 
the Anopheles mosquito has now adapted to grow in polluted waters as 
Culex mosquitoes. Hence the limitation barrier in the cities as been 
bypassed favouring multiplication of Anopheles mosquito in the city's. 
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STABLE  TRANSMISSION: 
A continuous exposure to a fairly constant and high rate of malarial 
parasite in the tropical regions such as sub Saharan Africa results in 
development of partial immunity. The average entomological inoculation 
rate is greater than 10,  hence people living in this area develop resistance 
at a younger age, this contributes to the stable transmission in this area. 
UNSTABLE  TRANSMISSION: 
 The areas with entomological inoculation rate of less than five the 
acquired immunity is not developed.  The population remains vulnerable 
to the infection.  All the age groups affected,  the frequency and severity 
of malaria increases as the mosquito density and biting rate increases 
rapidly example  Asia.    India falls into this group of population where 
there is unstable transmission and the people are  prone  for  the  infection  
and its complications. 
14 
 
 
FIGURE 1 MALARIA  ENDEMIC  AREAS  IN  INDIA 
  
HYPOENDEMIC--<10%. 
MESOENDEMIC--10%-50% 
HYPERENDEMIC--50%-75% 
HOLOENDEMIC-->75% 
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GENETIC   FACTORS : 
In areas of stable transmission, where the entomological 
inauguration rate is greater than 10 per year the human body adapts 
genetically to this infection by forming resistance to it. 
1) Duffy negativity of the RBC's protect against Plasmodium 
vivax. This has virtually led to the elimination of malarial parasite in the 
African countries
11
. 
2) Thalassaemia causes 50% reduction in malarial infection.
11 
3) homozygous haemoglobin C – 90% reduction. 
4) haemoglobin E and ovalocytes carrier state protect Plasmodium 
falciparum and Plasmodium vivax. 
5) sickle cell anaemia gives 90% protection. 
6) G6PD gives 50% production against infection. 
LIFE   CYCLE: 
In the life cycle of malarial parasite man forms the intermediate 
host since he harbours the asexual form of the parasite. 
1) human host – asexual phase – intermediate host. 
2) mosquito – sexual  phase – definite host. 
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IN  THE  INTERMEDIATE  HOST  MAN: 
In humans, the malarial parasite existing various forms forming a 
complex life cycle, this enables the parasite to live in different adverse 
environments in the body. 
The bite of the female Anopheles mosquito inoculates the 
sporozoite into the bloodstream, within minutes the sporozoites reaches 
the liver parenchyma. 
Amplification of the parasite occurs in two step process. The first 
phase forms the hepatic phase. Here the tissue  scizhonts increase in 
number to about 10^2 to 10^ 14. The second step occurs on the RBC, this 
is called the area erythrocytic phase. 
In the liver (schizont) undergo multiplication and at one stage burst 
out of the liver. They are released into the circulation and are called the 
merozoites. 
 The hepatic  phase of malarial parasite, the patient remains 
asymptomatic. The reason for the lack of specific symptoms is that the 
schizonts are remaining intracellular. There not exposed to the host 
defences and they are not eliminated. 
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ERYTHROCYTIC   SCHIZOGONY: 
The tissues SCHIZONTS of the release from the liver cells are 
called  MERROZOITES.  
There are two types of phenomenon after rupture of liver PHASE 
parasites – one the Plasmodium falciparum/Plasmodium malaria – do not 
reinfect the cells. Second Plasmodium ovale/Plasmodium vivax persist in 
the liver as Hypnozoites. 
Inside the RBC the parasite transfers into ring forms which 
enlarges into early trophozoites. 
Staining with Romanowsky or Giemsa stain can be done and 
trophozoites and merozoites can be seen. The trophozoites multiply and 
released in circulation as erythrocytic  schizont. 
The trophozoites converted to late trophozoites by feeding on the 
haemoglobin present on the RBC. The haemoglobin is only partially 
metabolised leaving behind the malarial pigment called hemozoint 
pigment. 
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          The late trophozoites give rise to early schizonts which on 
multiplication converted to late schizonts and released into the 
circulation. The cycle keeps repeating. 
      With each spike of fever the RBC's lysis occurs, erythrocytic 
schizonts are released and the cycle gets synchronised. 
Table 1: Characteristics of Plasmodium species infecting humans 
Characteristic  
feature 
Plasmodium 
falciparum 
Plasmodium 
vivax 
Plasmodium 
ovale 
Plasmodium 
malariae 
Exo- 
erythrocytic 
phase (days) 
5.5 8 9 15 
Hepatic phase 
number of 
merozoites 
30,000 10,000 15,000 15,000 
Erythrocytic 
phase duration 
in hours 
48 48 48 72 
Red blood cell  
preference 
Younger 
cells 
Reticulocytes Reticulocytes Older cells 
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GAMETOGONY: 
Over time, some of the merozoites develop into male, female 
gametocytes and enters into the mosquito during their blood meal, fuse in 
the stomach of the mosquito forming the zygote hence completing the 
malarial life cycle. 
The male and female gametocytes entry into mosquito and 
reproduction by sexual means marks their sexual phase of the malarial 
life cycle. The host being the definitive host. 
 The minimum concentration of gametocytes required to infect the 
mosquito is 12/cubic millimetre of blood. Apart from forming the 
infective stage of the life cycle they do not produce any pathological 
effects in the host. The gametocytes if they do not fuse, that this they are 
not taken up by the mosquito then they wither of in a few days time. 
The formation of the gametocytes occurs in the spleen in the bone 
marrow whereas in the peripheral blood only the mature forms of the 
parasite are seen, the premature forms are found in the spleen and bone 
marrow. This constitutes the carrier or reservoir of infection. 
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                            Fig 2: LIFE CYCE OF MALARIA 
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RELAPSE 
When resource of malaria infection is an EXO-erythrocytic phase 
then it is called relapse. 
Exo – erythrocytic source such as the liver is seen in Plasmodium 
vivax, Plasmodium ovale. 
The merozoites in the liver after multiplication bursts open the 
hepatocytes and enters the blood. It has been considered the released 
merozoites are two sizes. The smaller ones runs into the blood, the larger 
ones remain in the liver. This reinfect the liver and forms the basis of the 
next relapse. The cells are called the hypnozoites. 
HYPNOZOITE  THEORY: 
In certain species of malaria, that is Plasmodium ovale and 
Plasmodium vivax, this SCHIZONTES multiply in the liver to release 
two types of merozoites. 
The smaller sized merozoites are released into the circulation and 
causes clinical manifestations. 
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            The larger ones reinfect the liver cells and remained dominant in 
the cells. These are called the hypnozoite's and are responsible for relapse  
RECRUDESENCE: 
This is caused by survival of the parasite in the erythrocyte for long 
periods at low levels escaping the host defence mechanisms. This is seen 
in certain species of malaria such as Plasmodium falciparum. 
  There is total absence of parasite in the tissue phase, hence radical 
cure with primaquine is not required for this type of malaria. Hence the 
distinction between recrudescence and relapse becomes important to plan 
the further course of management. 
The usual treatment given for malaria is to cure the disease, and 
cure the disease there is a need for early identification of the infection and 
also the type of infection.weeks, months, years later. 
MALARIA  AND  HUMAN  HOST: 
The malarial parasite escapes the host defence mechanism by the 
following means, 
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1) Antigenic diversity, clonal antigenic variation: each Plasmodium 
has different antigens as well as the change in the antigenic structure 
during the course of infection. 
2) Immune modulation:   Hemozoin in the malarial cell decreases 
the maturation of antigen presenting cells such as the macrophages which 
ingest these have pigments present in the bloodstream or RBC. This 
results in immunosuppression and the aggravation of bacterial infections 
during the course of malarial infection. 
On entry into the human immune system there is activation of non-
specific immune response, humoral response such as non-specific 
polyclonal activation and the specific Ig. 
Non-specific activation of immune system – there is non-specific 
polyclonal activation of the immune system who significance is not 
known. The natural killer cells produce interferon, in response to 
parasitised RBC leading to macrophage activation and causing the death 
of RBC. 
 Interleukin eight the pro-inflammatory cytokine aggravates the 
immune response to the  malarial parasite.                                                                                                      
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(3) The development of cellular defence mechanism are impaired 
in protein energy malnutrition
11
, HIV infection
12
, antigenic diversity of 
the malarial parasite, lack of major histocompatibility complex on the 
surface of infected RBCs. 
PREMUNITION: 
             It is the immunity in the host mediated by the presence of parasite 
itself and not as a result of previous infection. In areas such as sub-
Saharan Africa
2
 the entomological inoculation rate exceeds greater than 
10 to about 70 per day. This results in high blood levels of parasitaemia 
and activation of host immune responses. The end result the individual 
remains partially immune to the infection. This is known as premunition. 
PATHOPHYSIOLOGY: 
Malarial infection in human beings resulting clinical manifestations 
which are a result of the following for pathological events, 
1. fever 
2. pallor due to anaemia 
3. immuno pathological events 
4. tissue anoxia. 
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All the acute events are caused by the blood stage malarial parasite 
and not by the intracellular located malarial parasite. 
a) Anaemia – in infection with malaria anaemia results due to haemolysis 
during the febrile paroxysm, the parasitised RBCs also taken up by the 
spleen (splenic sequestration). The bone marrow undergoes suppression 
due to the inflammatory cytokines released by the blood stage malarial 
parasite when the RBC lysis during the febrile paroxysm. 
b) Immuno pathological events – non-specific polyclonal activation of B 
lymphocytes occurs in malaria leading onto various immune complex 
mediated diseases. The TNF alpha released during the inflammation also 
causes deteriorating effects in the patient. 
c) Tissue anoxia – the infected RBCs adhere13 to the vascular endothelial 
cells resulting in tissue anoxia, hypoglycaemia and lactic acidosis. This is 
especially true in the case of Plasmodium falciparum infection. It can also 
result in leakage of blood, protein and tissue fluid. The result of the above 
pathological purposes causes failure of organ system in which it occurs 
(liver, heart and kidney). 
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CLINICAL  FEATURES: 
Incubation period is the time interval between the infection and the 
onset of clinical symptoms or signs. The duration is variable for each 
species of malaria, 
             1) Plasmodium vivax           –    12 – 17 days 
             2) Plasmodium ovale             –   16 – 18 days 
             3) Plasmodium falciparum     –    9 – 14 days 
             4) Plasmodium malariae         –   18 – 40 days 
The incubation period is subjected to change i.e.,  increase in case 
of a patient having partial immunity to the parasite or had incomplete 
chemotherapy
11
. 
UNCOMPLICATED  MALARIA: 
The classical presentation of a malarial fever is,  child having 
paroxysms of fever, in between the febrile periods child shows relative 
wellness with mild fatigue. 
Paroxysms: – each paroxysm coincide with the rupture of RBC 
releasing the schizont. This paroxysm of fever has three stages ie hot 
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stage, sweating stage, cold stage
8
. On an average each episode of 
paroxysm may last for about 8 to 12 hours. The paroxysm intervals vary 
with the species of malaria, Plasmodium vivax lasts 48 hours, 
Plasmodium malaria last 72 hours, Plasmodium ovale lasts 48 hours, 
Plasmodium falciparum less apparent occurs in mixed infection. 
Non-specific signs/symptoms: – fever, chills and rigours, sweat, 
myalgia, abdominal pain, vomiting, pallor, diarrhoea, jaundice
11
. 
COMPLICATED/ SEVERE  MALARIA: 
As already mentioned the blood stage parasites are responsible for 
clinical manifestations in uncommitted malaria as well as the complicated 
form. Hence the parasitaemia of greater than 5% causes symptoms 
consistent with complicated severe malaria. Plasmodium falciparum is 
the most common reason for complications. 
The clinical features to say severe malaria
11
 are the presence of 
a) altered level of consciousness, 
b) prostration, 
c) multiple seizures, 
d) respiratory distress, 
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e) icteric, 
f) cola coloured urine indicating haematuria, 
g) abnormal bleeding, 
h) severe pallor 
i) pulmonary oedema 
CEREBRAL  MALARIA: 
Plasmodium falciparum forms the most common cause of cerebral 
malaria, Plasmodium vivax rarely causes this entity. 
This complication of Plasmodium falciparum occurs in persons 
with low level of immunity against the disease. Hence it occurs in young 
age group and adults living in areas of low transmission. 
WHO defines cerebral malaria
11
 as follows: 
a) after seizure in the child does not regain consciousness of greater 
than 30 minutes; if other causes of encephalopathy like bacterial and viral 
encephalopathies
15
 are ruled out. 
b) evidence of Plasmodium falciparum in the peripheral blood 
smear examination
15
. 
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Pathology of human cerebral malaria. 
The knobs that are formed in RBC infected with Plasmodium 
falciparum adhere to the walls of the vessels. These knobs are formed by 
HRP 1 and 2. This leads to obstruction of the cerebral microvasculature 
resulting in small, petechial haemorrhages present over the white matter, 
the grey matter is always spared. 
DURCH'S  GRANULOMA: 
At the site of microvasculature obstruction, ischaemia results and 
small haemorrhagic foci is formed.   It is surrounded by  glial cells
15
.   
There is an increase in the metabolic demands of the brain sends in 
addition to brain cells there are infected RBCs requiring glucose.   This 
leads to increase in the cerebral blood flow
11
 and a result there is also an 
increase in the intracranial pressure. 
Coma in malaria is hypothesised to occur as a result of  
cytokines mediated nitric oxide release which act as a inhibitor of 
neurotransmission in the brain. 
CLINICAL  FEATURES: 
The child presents with altered level of consciousness which ranges 
from drowsiness, confusion to coma. 
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Physical examination reveals the temperature of 106 -108 degrees 
Fahrenheit with  seizure or muscle twitch or rhythmic movement of head 
and extremities.  Fundoscopy
12
 reveals retinal haemorrhage with unequal 
dilated pupils and other signs of upper motor neuron lesions are seen. 
Lumbar puncture if done reveals increased intracranial pressure, 
normal glucose/protein concentration. The EEG remain normal. 
Once treatment is started at the earliest recovery is generally 
complete. Delay in the treatment increases the risk of morbidity and 
mortality. Some children recover with sequelae such as aphasia, mental 
retardation hemiparesis, ataxia
11
. 
HEMATOLOGICAL  ABNORMALITIES: 
1)  Anaemia: – the anaemia encountered in malaria is a normocytic 
normal chromic anaemia. There is no elevation of  reticulocyte 
count. This anaemia is the result of  haemolysis of infected cells, 
sequestration of the spleen, this erythropoiesis, Blackwater fever
11
. 
2)  Low platelet count: – this results from mainly due to infection with 
Plasmodium falciparum. 
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3)  DIC
11
: – it results from activation of coagulation by the pro-
inflammatory mediators present in the blood as well as the infected 
RBCs. 
4)  Hypoglycaemia: – hypoglycaemia in malaria results from three 
possible predisposing factors, 
                a) children    
                b) pregnant woman   
                c) Quinnine therapy 
The act at various steps of the glucose utilisation like inhibition of 
gluconeogenesis, excessive glucose utilised by the parasites
11
, activation 
of insulin secretion by quinine
12
. 
Hypo glycaemia causes a decrease in the sensorium of children as 
often confused with cerebral malaria. Hence  identification of cerebral 
malaria induced hypoglycaemia and infection induced altered level of 
consciousness becomes of prime importance. The differentiation is not 
possible clinically hence only repeated blood sugar monitoring can solve 
the issue. 
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LACTIC  ACIDOSIS: 
The result of microvasculature obstruction by parasitised 
erythrocytes causes tissue anoxia as discussed earlier. This forms the 
major route for formation of lactic acid and the clinical condition lactic 
acidosis. 
The measurement of plasma bicarbonate
12
 and lactate concentration 
form the objective way of measuring the degree of lactic acidosis.
 
Other sources of lactate is the lactate produced by the malarial 
parasite and hepatic and renal failure which fails to clear the normally 
produced lactate
12
. 
BLACK WATER   FEVER:  
Intravascular haemolysis occurring due to malaria especially 
Plasmodium falciparum can be significant enough to produce a condition 
called Blackwater fever. It clinically presence with haemoglobin in 
patient with malaria. Predisposing factors are, 
  1)    G6PD deficiency on quinine therapy. 
  2)    Child receiving quinine, 
  3)     G6PD
11
 deficiency patient receiving oxidant drugs. 
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Blackwater fever can be simply told as an indicator of sudden 
intravascular massive haemolysis. It need not indicate any specific 
disease. It mostly seen in the malarial infection due to falciparum. 
ACUTE  RENAL  FAILURE  IN  FALCIPARUM: 
Acute renal failure is a feature of complicated malaria often seen in 
adults than children. There are two types of acute renal failure ie it can 
occur as an end result of multiple organ dysfunction syndrome or it can 
be a isolated event. 
Acute renal failure occurring as an isolated event as a better 
prognosis than the one presenting as a part of the systemic event. The 
presentation of acute renal failure in malaria is an acute tubular necrosis. 
Very few cases develop glomerulonephritis
12
.  
MALARIA  IN  PREGNANCY: 
In pregnancy, the placenta exhibits an adhesion receptor namely 
the chondriotin sulphate a on the surface of the placenta. The parasitised 
RBC gets attached to the placenta and impair the blood flow to the fetus. 
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The manifestation of the disease in the baby depends on a few 
factors such as the transmission intensity, and the immune status of the 
individual patient. 
In areas of high transmission, the mother would have had high 
level of acquired immunity hence the disease does not manifest and 
remain asymptomatic in the mother as well as the fetus since passive 
transfer of immunoglobulins to the fetus occurs in pregnancy and 
breastfeeding. The anaemia caused by the haemolysis in the course of the 
disease can lead to fetal hypoxia and low-birth-weight
12
. 
 In areas of low transmission, the level of acquired passive 
immunity is low hence the host living in this region are vulnerable to the 
complication of malaria. Here there are more incidence of spontaneous 
abortion, prematurity, stillbirth, low-birth-weight. 
Maternal HIV also contribute to the increase in the fetal loss and 
congenital malaria since here again there is low acquired immunity.  
In this condition the patient is not able to mount an immune response. 
PREVENTION: 
WHO advises prevention of malaria during pregnancy by 
undertaking the following measures, 
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1) use of insecticide nets of long-lasting type, 
2) use of proven to therapy with sulphadoxine – pyrimethamine,  
3) early diagnosis and effective management. 
MALARIAL  HEPATITIS: 
When the bile pigment synthesis reaches six times normal, the 
bilirubin rise is only 2 mg/dL. The liver has a very large reserve capacity 
so that it can compensate for this rise of bilirubin load. 
Sometime severe jaundice is noted in the course of malarial 
infection, this cannot be purely due to haemolysis alone. Associated 
hepatocellular damage and cholestasis contribute to this rise of bilirubin. 
In falciparum malaria, the liver enlarges and appears congested and 
dark brown pigmented. Kuffer cell hyperplasia along with dilated 
sinusoides and chronic infiltrates around the portal tracts. 
The histopathological change predominant in the infected liver is 
Kuffer cell hyperplasia, malarial pigment Hemazoin
11
 and congestion of 
the liver. 
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             Clinical features        
 
Age less than three years 
Decerebrate posturing 
Deep and prolonged coma 
Convulsions/ seizure. 
Haemorrhage within the retina. 
Absent corneal reflex. 
Organ dysfunctions. 
                 Laboratory tests 
 
Hyper parasitaemia greater than 5% 
haemoglobin <7gms, PCV<20% 
leucocytosis. 
Hypoglycoracchia 
CS of lactic acid greater than 6 
mmol per litre. 
Low antithrombin 3. 
Increased plasma nucleotidase. 
B. Urea greater than 60 mg/dL . 
B. Glucose <50 mg % 
peripheral schizontemia 
S. Creatinine greater than 3 mg/dL 
 
Table 2: Factors causing poor prognosis in cerebral malaria 
CONGENITAL  MALARIA: 
Congenital malaria occurs in babies born of nonimmune mothers, 
infected with Plasmodium falciparum or Plasmodium vivax. The 
manifestations in the baby are seen around 10 to 30 days postnatal period. 
The newborn shows signs and symptoms like fever, restlessness, 
pallor, jaundice, tiredness, loose tools, enlargement of liver, enlargement 
of spleen, bluish discolouration. 
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 Congenital malaria is an important cause of abortion/premature 
birth/stillbirth/intrauterine death
11
. If there is no transmission to the fetus 
then it can result in IUGR. 
TRANSFUSION  MALARIA: 
  Many infections transmitted by blood transfusion of which malaria 
remains as one of the common causes. Two situations are encounter, 
       1) In an nonendemic areas, donor deferral along with screening of 
blood specific malarial immunoglobin eliminates trans mission. 
        2) In endemic areas identification of infected donors becomes tough. 
It can be made sensitive by specific questioning of the donor, looking into 
the seasonal and geography variation, if the donor is found positive 
antimalarials before transfusion might help. 
NOSOCOMIAL  MALARIA: 
This transmission of malaria has been reported in a few cases and 
in a few settings, they are 
1) The use of the same multidose heparin container among 
different patients in the hospital. 
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2) Reuse of single use saline flushes as resulted in nosocomial 
spread of malaria. 
3) I V drug
14
 addicts who share the same needle get the infection 
from their partners. 
There is essentially no difference in the manifestation and 
management of malaria as with natural infection. 
CHRONIC  COMPLICATIONS  OF  MALARIA: 
          1) chronic anaemia, 
          2) failure to thrive, 
          3) vulnerability to infection, 
          4) specific syndromes – tropical splenomegaly syndrome, nephrotic 
syndrome, Burkitt's lymphoma, Endo myocardial fibrosis. 
TSS  SYNDROME  (tropical splenomegaly syndrome): 
This condition is also known as hyper reactive malarial 
splenomegaly syndrome, occurring in malaria endemic countries such as 
the sub Saharan Africa and the Indian subcontinent. 
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Repeated malarial infection leads to overstimulation of the immune 
system. When this occurs over a long period of time the mononuclear 
macrophage system gets activated and does the clearance of immune 
complex. The end result enlargement of spleen. 
The spleen shows dilated sinusoides, marked erythro- 
phagocytosis, lymphocytic infiltrates. The peripheral smear is devoid of 
malarial parasite and turns out to be negative. The following features 
should be present to call tropical splenomegaly syndrome, they are 
a) massive splenomegaly 
b) marked increase in IgM
12
 and antimalarial antibody, 
c) enlargement of liver with Kuffer cell hyperplasia, 
d) B-cell lymphocytosis. 
All the marrow cells in all cell lines are decreased due to 
splenomegaly leading onto pan cyto penia. 
TREATMENT: 
Since continuous antigenic stimulus form the basis of the disease 
the treatment is directed towards the removal of the stimulus. 
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Chemoprophylaxis results in removal of the stimulus and return of the 
system to normal in three months
11
. 
In certain situations continuous stimulation can lead to 
lymphoproliferative disease.  
ENDEMIC  BURKITT'S  LYMPHOMA 
The malarial parasite produces pigment called haemozoin. 
Hemazoin is a breakdown product of haemoglobin after partial utilisation 
within the RBC by the malarial parasite. 
This material released on RBC lysis enters into the circulation. It is 
taken up by the reticulo-endothelial system.  The macrophage now 
becomes unable to mount an immune response. This leads to 
immunosuppression. 
Ebstein barr virus
12
 which remains under the control of the human 
immune system once immunosuppression occurs there is activation of the 
virus leading to Burkitt's lymphoma. 
QUARTAN  MALARIAL  NEPHROPATHY: 
Immune complexes formed as a result of Plasmodium malariae 
infection gets deposited in the basement membrane of the capillary. 
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  Ultra microscopic finding indicate sub endothelial region deposits 
of basement membrane like material arranged in p plexiform manner, 
either focal or segmental with a nephritic
12
 picture. 
In areas of low transmission treatment is given as recommended in 
the guidelines. 
 Removal of spleen has no role in the management. 
Three grades of nephropathy 1,2,3 are seen. Of these grade1 is 
granular pattern with good response to treatment.  2,3 poor response and 
the deposition is diffuse involving entire kidney. 
DIAGNOSIS  OF  MALARIA 
1) Microscopic examination: – 
The time-tested investigation in the diagnosis of malaria is the 
peripheral smear examination using the light  microscope.  The peripheral 
blood examination identifies the merozoites and trophozoites in the 
blood. None of the other stages of the malarial parasite can be identified 
in the smear examination.  
42 
 
                                                                                           
In certain situations the peripheral smear turns out to be negative, 
like partially treated or organisms are sequestered in the organs. In such 
situations the bone marrow examination yield to be fruitful. 
Two smears are prepared, one thick and one thin. The thick smear 
helps in the quick scan for the identification of the parasite. 
 The thin
16
 smear determines species type and also the percentage 
of RBCs which are infected. It also helps in the response to treatment. 
Sample collection: – 
The collection of blood for smear examination, the following 
precautions should be carried out 
a) administration of antimalarial treatment, alters the morphology 
and hence the yield of the smear decreases. 
b) ideal time for collection of samples for smear is after the febrile 
paroxysm
17
, nephropathy shows no response to any form of drugs such as 
antimalarial, cytotoxic or steroids. 
But this is not practically possible, so 4 to 6 hourly samples per 
day
16
 for three consecutive days will be accurate. Negative in all these 
can be taken as absence of infection. 
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c) blood should be collected with EDTA and smear prepared within 
two hours of collection though ideally as early as possible. 
Examination of blood film: – 
In a suspected case of malaria, smear is prepared and examined 
under oil immersion 100 X objective. After examining at least hundred 
fields, if no parasite could be identified then it is concluded as negative. 
Three consecutive days sample should be examined. 
Prognosticators in peripheral smear: – 
The microvasculature burden of parasite is not represented by the 
peripheral blood parasitaemia. Though peripheral blood smear is negative  
the microvasculature remains loaded with the parasite. 
The schizont in the microvasculature rupture to release 32 
merozoites. This results in an exponential rise of parasitaemia, high 
schizont count is an early marker of complicated malarial infection. 
           Account of greater than 10^ 4 parasites (schizont and trophozoites) 
high sensitivity/specificity of fatal outcome. 
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Plasmod
ium 
species 
Stages 
found in 
circulating 
blood 
Appearan
ce of 
RBCs – 
SIZE 
Appearanc
e of RBC's 
–
STIPPLING 
Appearance 
of parasites 
–
CYTOPLASM 
Appearance 
of parasites 
–PIGMENT 
Pl.    
falcipar
um 
Trophozoi
tes, 
gametocyt
es 
 
Normal 
clefts or 
dots seen 
called as 
Maurer's 
Rings small 
and delicate 
with doubled 
or inside the 
rings 
Gametocyte
s it appears 
black 
course and 
conspicuous 
Pl. 
vivax 
All: 
gametocyt
es 
schizonts 
trophozoit
es 
Maximu
m size 
1.5 –2 
times, 
enlarged 
Dots may 
be present  
Schuffner'
s dots 
Appear light 
blue with 
irregular 
spreadout 
appearance 
amoeboid 
trophozoites 
Golden 
brown 
inconspicuo
us 
Pl. 
ovale 
All: 
gametocyt
es 
trophozoit
es 
schizonts 
Maximu
m size 
1.25 – 1.5 
times 
enlarged 
Schuffner'
s dots may 
be present 
Dark to 
medium blue 
rounded 
compact 
trophozoites 
Dark brown 
conspicuous 
Pl. 
Malaria
e 
All: 
gametocyt
es 
trophozoit
es 
schizonts 
 
Normal 
Ziemann's 
dots rarely 
seen 
dark blue 
with dense 
cytoplasm; 
band form 
trophozoites 
occasionally  
round 
compact 
trophozoites  
Dark 
brown, 
course, 
conspicuous
. 
 
Table : The  peripheral  smear  of  different  malarial  parasite. 
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2)  Quantitative  buffy  coat : – 
          Q BC is done on the principle of acridine  orange stains the DNA 
content of the cell. The red blood cells are devoid of nuclear acids hence 
they are not stained. The parasitised RBCs containing the organism 
plasmodia contain DNA of the organism which gets stained with acridine. 
The buffy coat is prepared on the principle of density gradient 
centrifugation of blood.  The anti-coagulated blood centrifuged with 200 
XG for 10 minutes. The cells are precipitated in the following order.  The 
RBCs form the bottom layer followed by the WBCs about them and 
platelets above them. The RBCs containing organism are formed of the 
top layer of the RBC column. Using fluorescence microscopy the RBC 
containing parasite can be visualised
20,21,22
. 
          The main drawback of the Q BC is that all cells containing the 
DNA
19
 gets stained and hence differentiation from the parasitised RBC 
becomes important. The cells the stained are Howell jolly bodies seen in 
haemolytic anaemia, breakdown cells whose nucleic acid DNA mimics as 
parasites. 
           This method showed a sensitivity of 41% – 93% and a specificity 
of 52% to 93% for Plasmodium falciparum and non-Plasmodium 
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falciparum species
23,24
.  This is one of the common test done in our 
hospital for the detection of malaria, the chief drawback is the delay in 
results. 
RAPID  DIAGNOSTIC  TEST: 
The presence of malarial parasite releases certain antigens into the 
blood. These antigens are detected by antibody coated strips in the mobile 
phase. This forms the basis of rapid diagnostic tests. 
Principal: – 
          Monoclonal antibodies prepared against specific target antigens of 
malarial parasite are used. This antibody conjugated with selenium dye or 
gold particles forms the mobile phase. Nitrocellulose strips with 
monoclonal antibody  act as the immobile phase. The mobile phase 
allowed to move
29
 and captured by the immobile phase strip forming a 
visible line. 
          Based on the various targeted antigens multiple rapid diagnostic 
test are available in the market. The target antigens are HRP 
2/PLDH/Aldolase. 
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a)  Histidine rich protein 2:   
          This protein is exclusively produced by Plasmodium falciparum
25
 
in its gametogenic and asexual stages. It is a combination of histidine, 
Alanine, aspartate, with the major protein formed by histidine. Of the 
three types of HRP1,2,3 the second isomer is found universally in all 
Plasmodium falciparum species. The levels of HRP 2 clears in a period of 
7 to 14 days
26
 from the blood. Hence the test has certain limitations in the 
follow-up period. b)   p (LDH) or  
b) Plasmodium lactate dehydrogenase: – 
Plasmodium lactate dehydrogenase is an enzyme produced by all 
the species of malarial parasite infecting man. 
           The isoforms of each parasite unique hence differentiation in terms 
of isoforms into different species types in malaria is possible.  
The isoforms have no cross-reactivity with the human isoforms. 
           One advantage of this test is P LDH is produced only by viable or 
living organisms present in the body and not by the dead parasites. This 
makes it possible to detect level of clearance and drug resistance
19
 during 
the course of treatment. 
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c)  Ex-Optimal test: – 
Three lines are formed in the optimal test which identifies the 
Plasmodium lactate dehydrogenase enzyme. Two of the three lines are 
containing a pan lactate dehydrogenase detecting all the four types of 
malaria. One PLDH detects specifically Plasmodium falciparum malaria. 
The isoforms of PLDH do not show any cross reactivity with other 
other parasites such babesiosis
28
, leishmaniasis and other organisms. This 
improves the tests reliability and validity. 
d )  Plasmodium  Aldolase: – 
           Plasmodium aldolase has a glycolytic function in the body of the 
parasite as well as binding function to actin, adhesion (thrombospondin 
related anomalous protein – TRAP). This plays an important role in 
protein binding and blocking the microcirculation. Antibodies against this 
enzyme provide protective immunity against infection
29
. 
e)  Plasmodium glutamate dehydrogenase: – 
          The enzyme also has a role in carbon nitrogen metabolism. The 
enzyme galactose dehydrogenase provides oxidisable carbon source 
required for energy production as well as reduced electron carrier. It is 
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also an amino acid donor to other amino acids in  subsequent 
transamination reactions. 
Glutamate dehydrogenase enzyme is also produced by the living 
parasite and hence it can be used to detect the presence of viable 
organisms in the blood. 
The disadvantages of the rapid diagnostic test which limits its 
utility are as follows: 
1)  not able to identify mixed infection 
2)  the test kits are not able to stage the parasite development level, 
limiting its utility in surveillance. 
3)  rapid diagnostic test being expensive limits its usefulness in large 
scale field studies. 
4)  the proper function of rapid diagnostic test depends on the 
temperature, exposure to high temperature results are affected. So 
transport rural areas care should be taken to prevent exposure to 
high temperatures. 
5)  the person has persistent antigen in the body the test shows 
positive. This condition is a result of incomplete treatment. 
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POLYMERASE  CHAIN  REACTION (PCR) 
The PCR has the accuracy level of hundred percent to detect all 
species at all stages of the malarial parasite. The main disadvantage of the 
test is expensive equipments and the cost of the test. This PCR can 
replace microscopy
19
 for research purposes. 
 Table      : Comparison  of  microscopy  with  RDT 
 Microscopy Rapid diagnostic test 
Requirements   
    a) supplies Blood, staining reagents Blood collection 
    b) electricity Preferred Not necessary 
    c) equipments Microscope None 
    d) training Trained technician Minimal training 
   
Performance   
     a) subjectivity High Low 
     b) robustness Average High 
      c) labour-intensive High Low 
      d) test duration 60 minutes 20 minutes 
   
Technical 
specifications 
  
     a) threshold 5-10 parasite/microlitre 40-100 
parasite/miclit 
      b) detect all species Yes No 
      c) quantification Yes No 
 
51 
 
                                                                                           
MANAGEMENT
6 
a)  In areas where Plasmodium is sensitive to chloroquine; 
           chloroquine a total dose of 25 mg/kg is given in this situation. It is 
given in the following order.  Day  1 – 10mg/kg single-dose 
day2 –10mg/kg single-dose 
         day3 – 5mg/kg single-dose. 
          Vivax: radical cure is achieved by adding primaquine 0.25 mg/kg 
per day for a period of 14 days. 
          Falciparum: primaquine 0.75 mg/kg stat dose for the sexual stages 
of the malarial parasite. 
b)  Chloroquine resistant Plasmodium falciparum: 
         artesunate – 4mg/kg od  for three days d1, d2, d3  
plus 
sulfodoxime-pyrimethamine single-dose on day one.  
                                                     or 
          artesunate 4mg/kg once-daily on  d1,d2,d3    
          mefloquine  25mg/kg divided doses on day two, day three       
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                                                       or 
     Artemether 20 MG +120 MG Lumefrantine six doses bd on day1 ,2,3. 
c)  MDR  Plasmodium falciparum: 
           quinine  10mg/kg per dose three times a day for seven days 
                                                       plus 
           doxycycline  3.5mg/kg once-daily for seven days 
            (or)  tetracycline  4mg/kg per dose four times a day for seven days 
            (or)  clindamycin  20mg/kg per day twice-daily for seven days 
If the patient develops quinine toxicity also called Cinchonism, 
             quinine 10mg/kg per dose three times a day for 35 days 
             (plus) tetracycline (>8 yrs)  4mg/kg per dose four times a day 10 
days 
               (or)    doxycycline  (> 8yrs) 3.5mg/kg once-daily for seven days 
                (or)    clindamycin 20 mg/kg per day twice-daily for seven days 
Primaquine   0 .75 mg/kg single-dose for children greater than one year to 
destroy the sexual stages in the falciparum malaria. 
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d)  ACT – artemisinin combination therapy 
          There is a very rare chance of failure with ACT therapy for  
14 days. 
In case of an event of failure to chemotherapy it should be 
confirmed by blood smear examination. The patient should be enquired if 
he had vomited the drug or he has missed out the drugs. In the case of 
failure of treatment retreatment with ACT is done. 
e)  NAMP regimen for complicated/severe malaria: 
     1) quinine salt:   
Loading dose 20mg/kg in 10ml/kg of 5% dextrose over four hour 
followed by, maintenance dose – 10 mg/kg for two hours repeated every 
8 hrs. 
If the patient is able to swallow then changeover to oral quinine     
Oral  quinine 10mg/kg eight hourly for seven days plus tetracycline or 
doxycycline or clindamycin for seven days. 
I.V. Access is not available then, quinine can be given IM at the 
same dose as IV on the Antero lateral thigh. This can also be given when 
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quinine cannot be given IV. IM quinine is diluted in normal saline  
60 – 100mg/kg along with tetracycline/doxycycline/clindamycin. 
2)    artesunate: – 
            2.4mg/kg IV at 12, 24, 48, 72 hours for seven days 
            if there is no vomiting them daily same dose given orally along 
with Tetra, Doxy, Clinda. 
(Or)  artemether: 
           3.2 mg/kg IM given as a loading dose followed by 1.6 mg/kg OD 
for six days. 
            If there is no vomiting, daily oral dose along with any one of the 
three Tetra/Doxy/Clinda for seven days 
SUPPORTIVE  MANAGEMENT
6
: 
1)  cardiopulmonary cerebral assessment should be done for all cases 
of malaria (complicated/severe) to identify shock. 
2)  antimalarials drug should be administered without delay since 
delay can cause progression of disease even in a short span of two 
hours. 
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3)  aspiration can be prevented by NG tube insertion if ALOC present. 
4)  ventilator support if needed. 
5)  antiepileptic drugs as required for the situation. 
6 )  threat febrile paroxysms. 
7)  blood transfusion/exchange transmission has indicated 
8)  supportive care for acute renal failure 
9)  measure parasitaemia from time to time. 
CONTROL: 
The spread of malaria at the community level can be blocked by 
the following measures
10
. 
a)  intervention through community participation. 
b)  vector control: mosquito breeding increases the vector density this 
can be reduced by certain measures, 
          # insecticide spraying such as malathion, ultralow volume fogging. 
         # Anti-larval measures such as Gambusia, lebister reticularis which 
feeds on the mosquito can be used. 
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         # Oiling the stagnant water so that oxygen to the organism is cut 
off. 
         # Proper disposal of waste water to prevent stagnation and mosquito 
breeding. 
        # Self protection done by using nets, repellents
5
 etc.. 
b)  early diagnosis and treatment: – the next step in the control of 
transmission through the vector is to block infected persons from 
infecting the mosquito so that they do not spread the disease. 
CHEMOPROPHYLAXIS
11 
Individual visiting endemic areas are at risk of acquiring malaria 
and on return to their state there is a chance of spreading the disease. 
Chemoprophylaxis using antimalarials one week before to 4 weeks after 
leaving the area prevents spread . 
Chemoprophylaxis:  
If chloroquine sensitive, consider use of chloroquine 5mg/kg 
weekly along with or proguanil 3mg/kg daily. 
          If chloroquine resistant, consider use of mefloquine 5mg/kg weekly 
if unavailable along with Doxy 2mg/kg. Daily 
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DRUG  RESISTENT
34
: 
              Resistance to chloroquine is mainly noted in malaria caused by 
falciparum. The resistance can be divided into four grades they are as 
follows. 
        S: sensitiv E:   if there is no parasitaemia on day six of treatment and 
the absence of recrudescence or date 28 
         R1 : low-grade resistance: recrudescence in the past two weeks is 
also called early and if it occurs second to fourth week's call. 
          R2 : high-grade resistance: the parasite density is clearway the 
spleen. Parasite density of greater than 75%, but it could not be 
completely cleared. 
          R3: when the is no clearance of parasitaemia on completion of 
treatment at 48 hours and thereafter. 
MALARIAL  VACCINES 
Vaccines are an integral part of preventive medicine, but as far as 
malarial infection is concerned there are certain limitations. These 
limitations are discussed below. 
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The malarial parasite undergoes a series of stages in its 
development ie complexity in its life cycle. At each stage the parasite 
undergoes antigenic variation with deffers the body and us from 
producing a vaccine which can specifically hit the target. 
           The focus of vaccine lies on the three stages of development that is   
a)  sporozoite: this is the infective stage of the malarial parasite from 
mosquito. Blocking this stage prevents man getting infect. 
b)  merozoites: erythrocytic invasion is done by these merozoites, 
blocking them can about the erythrocytic phase of the malarial 
parasite. 
c)  gametocyte: an effective vaccine against the gametocytes when the 
infection of the mosquito hence preventing spread. 
Cocktail vaccine: 
Multiple antigens are involved in the life cycle of malaria hence a 
single vaccine against a single antigen might not prove to be effective so 
it has been hypothesised that vaccine against multiple epitopes in a single 
vaccine is required. This type of vaccine is called the cocktail vaccine. 
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Vaccines available: 
a)  MSP1 and MSP2 vaccine: merozoites surface antigen 1&2 
b)  erythrocyte binding antigen 175 
         c)  gametocyte antigen Pfs 25
35 
 
Fig 3: Sites in the malaria life cycle that could be interrupted by 
VACCINE
2 
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1)  The life cycle of the malarial parasite starts at the injection of 
Plasmodium species during the blood meal of the mosquito 
(sporozoite). 
2)  Sporozoites reach the liver in a few minutes time. Multiplication of 
the sporozoites takes place for the next 7 to 10 days, during the 
period the patient remains asymptomatic. 
3)  After the development in the hepatocyte the merozoites are 
released in the form of vesicles. The merozoites reaches the lung 
capillaries breaks the vesicles freeing the merozoites into the 
circulation. 
4)  Merozoites enter the RBCs and multiply asexually, on completion 
multiplication the RBCs lysis and the parasites are released. They 
are ready to infect fresh RBCs. 
5)  In some RBCs multiplying by asexual means stops and 
gametocytes are produced which mature to form gametes. 
6)  Gametocytes are ingested by the mosquito and further fusion and 
development occurs in the stomach of the mosquito. 
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7)  Ookinetes burrow the midgut wall of the mosquito and forms 
oocyst, in the oocyst several hundred sporozoites are developed 
and burst to release. 
8)  The sporozoites released from the that enter the blood and through 
the circulation they reach the salivary gland of the mosquito. They 
reside here and during the blood meal they enter the circulation of 
their intermediate host. 
METHODOLOGY 
SELECTION  OF  CASES 
The  study  conducted  on  children  1yr  to  12yr  with  clinical  
features  of  malaria  meeting  the  inclusion  and   exclusion  criteria in  
op/ Ip  visiting  our  paediatric  department 
INCLUSION  CRITERIA 
• Children 1-12  year  age  with  clinical  signs  of  malaria 
• Clinical signs- fever with chills and rigors, pallor,  
splenomegaly  
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EXCLUSION  CRITERIA 
• Age  <1 yr or  >12  yr 
• Already  on  treatment,  partially  treated  in  past  4  weeks 
• Children  having  renal,  liver,  lung  disorders 
METHOD  OF  STUDY 
1) COLLECTION  OF  SAMPLE : About 160 cases  attending  
op/ip  cases  in paediatric  department,  patients  with clinical  features  of  
malaria  meeting   the  inclusion  and  exclusion  criteria  form the   study  
sample. Two  ml  of  venous  blood  drawn  under  strict  aseptic  
precautions  in a  sterile  edta  tube.                                                                                                                 
PERIPHERAL  SMEAR  STUDY: 
One thick blood smear and another thing blood smear were 
prepared from the sample collected. 
           A drop of blood is placed on the middle of the glass slide. The 
spreader usually the corner of another glass slide is used.  The spreader 
converts the drop of blood in half an inch square and then allowed to dry.  
Roughly the spreading is done to the other side is partly seen through the 
blood sample of smear. 
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A small drop of blood is placed at one end of the glass slide.  
A clean glass slide is used as a spreader. The edge of the glass slide is 
then kept at 45° angle with the slide containing a drop of blood on its 
side. The blood spreads between the edge and the plate of glass, the glass 
slide is lowered to 30° angle and pushed. The spreader is pushed till  
all the drop of blood is exhausted. The smear is thus prepared and 
allowed to dry. 
Both the glass slide one thin another thick are labelled. The thin 
slide is fixed with methanol.  
Fixing the smear: – the thin smear is dipped in methanol for five 
seconds to get fixed. The thick smear is not fixed. Staining the slide: – 
both the slides are stained with Leishmann's stain. Before staining the 
thick smear dehaemoglobinised using distilled water. Then dried smear is 
allowed to stand.  
With Leishman's stain for 30 seconds. The distilled water is 
allowed to remain over the slide for about 10 to 15 minutes. The slide is 
prepared is held under the tap water for a free flow of water over it. The 
slide is then dried by placing it in a slanting position, before placing to 
dry the back of the slide is rinsed with wet cotton. 
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           After the above procedure the thick and thin smears are loaded on 
a light microscope. The smears are examined under the 100 X objective. 
Multiple fields are searched in the thick smear for parasites. 
The entire procedure is done in 5 to 6 minutes, on average hundred 
fields are examined. The result is given negative if no parasite are seen at 
the end of examining hundred fields for five minutes. 
The species of parasite is identified using the thin smear, the stage 
of development can also be identified using the thin smear. The number 
of parasites per cubic millimetre is found using the thick smear, this is not 
done for all cases that are examined. 
RAPID  DIAGNOSTIC  TESTS: 
This is an immuno-chromatographic method to identify the 
malarial parasite using the HRP 2/PLDH antigens present in the human 
blood during infection. This is done using a commercial kit from SD  
bio line. 
Principal of the test: – HRP 2/PLDH as already explained are 
antigens detected.  
65 
 
                                                                                           
The monoclonal HRP2/PLDH antibody coated in the malarial strip. The 
appearance of test lines indicate positive result. The absence of along 
with the control indicate the card is invalid. The appearance of control 
line alone indicate the card is valid but the test is negative. 
Materials used: – 
                      1) a rapid test kit card. 
                      2) assay the diluent. 
                      3) micro pipette. 
Procedure: – the card is stored under room temperature. High 
storage temperatures alters the results. The card is placed on a horizontal 
flat surface, five Micro drops of blood is collected from the sample taken 
for smear examination using the sample collector which comes along 
with the kit. The sample of blood is placed in the small micro well of the 
card. Four drops of diluent is added into the larger on the card and 
allowed it to stand for 20 minutes. As the mobile phase passes through 
the immobile phase the following results are interpreted. 
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Interpretation: –  
  Negative – only the control line appear and the PF and pan lines 
does not. 
Positive – appearance of lines at T1 or T1 and T2 – Plasmodium 
falciparum 
Appearance of control line and T2 line – Plasmodium vivax                                      
Invalid – even the control line does not appear, the card is invalid 
Statistical analysis 
            The test results are obtained in the form of numbers and 
percentages. Chi-square test was done for categorical data and their 
relations with malaria positivity was noted. The sensitivity and 
specificity, negative predictive value and positive predictive value all 
pointing towards the diagnostic validity of the test was performed,  
To compare peripheral blood smear and rapid diagnostic test. The Kappa 
measure of agreement was applied to find of the correctness of the 
correlation. The P value less than 0.005 was considered statistically 
significant. All operation done using SPSS for Windows version 6. 
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Fig 4: Anopheline Vectors Of Malaria 
anopheles  stephensi 
 
                                          anopheles   gambia 
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Fig 6: Pl.falciparum gametocyte in thin blood smear.
 
 
 
Fig 7: Pl.falciparum ring stage in thin blood smear.  
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Fig 8: Plasmodium trophozoites in thick blood smear.  
 
Fig  9  :  RAPID  MALARIA  TEST  KIT  (HRP2/pLDH) 
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Fig 10:  Test  procedure  done  with  rapid  diagnostic  test 
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Table 6 : Distribution of positive cases by peripheral smear and 
HRP2/PLDH 
 Number Percentage Number Percentage 
Positive Cases 39 24.4   
Negative Cases 121 75.6   
Total 160 100   
Plasmodium vivax 28 71.8 
Plasmodium falciparum 11 28.2 
 
Of the suspected cases of malaria 39 cases were through positive 
and 121 cases were through negative by peripheral blood smear and 
malarial rapid diagnostic test. This constitutes 24.4% and 75.6% positive 
and negative respectively by both the tests. 28 cases were plasmodium 
vivax and 11 cases were plasmodium falciparum.  
Graph 1: Total positive cases distributed  by  either  method 
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Table  7 : Gender Distribution of Malaria Positive Cases. 
Sex 
Total no of 
Cases 
Positive 
Cases 
Percentage % 
Male 92 24 61.5 
Female 68 15 38.5 
Total 160 39 100 
(X2= 0.34; P =0.56) (Non - Significant) 
In the 39 cases, confirmed positive for malaria, male children 
constitute 15 (38.5%) and the female children constitute 24 (61.5%). 
There is no statistical significance between male and female sex wise 
incidence.  
Graph 3: Distribution of Malaria Cases sex wise. 
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Table 8 : Symptomatic distribution of Malaria in Children 
Symptoms 
No of 
cases 
No of 
positive 
cases 
Percentage 
% 
X2 P 
Fever 160 39 100 - - 
Chills and 
rigors  
77 20 51.2 0.58 0.75 
Sweating  16 6 15.6 1.66 0.20 
Headache  73 15 38.5 1.07 0.3 
Pain abdomen  49 14 35.9 0.68 41 
 
Of the 39 cases of malaria positives, fever was seen in all cases. 
Statistical analysis did not reveal any other symptoms to be consistently 
correlating with the disease. No cases had or showed any symptoms of 
severe malaria. 
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Graph 4: Symptomatic distribution of Malaria in children
 
Table 9: Signs in Children with Malaria. 
Signs 
Total no 
of cases 
No of 
positive 
cases 
Percentage 
% 
X2 P 
Pallor  77 25 64.1 5.27 0.02(HS) 
Splenomegaly 128 35 89.7 3.06 0.08(NS) 
Hepatomegaly 126 29 74.3 0.59 0.44(NS) 
 
Among the signs pallor was seen in 25 (64.1%) of cases being 
statistically significant (P<0.02). Spleen 35 (89.7%) and liver 29 (74.3%) 
in the positive cases. 
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Graph 5: Signs in children with malaria 
 
Table 10 : Weight correlation of Malaria cases 
Wt. for age% 
Total 
cases 
Positive cases 
Percentage 
% 
71%-80% 56 12 30.8 
>80% 104 27 69.2 
Total 160 39 100 
 
X2=0.4, P= 0.52 NS 
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There was no significant correlation in weight and incidence of 
malaria in our study. Greater than 80% weight group were 27 cases,  
71%-81% were 12 cases. 
Graph 6: Weight correlation of Malaria cases 
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Table 11: Hemoglobin in children with malaria 
Hemoglobin% Total cases Positive cases Percentage% 
6-8 81 11 28.2 
8-10 55 16 41.0 
>10 74 12 30.8 
Total 160 39 100 
    X2=5.44, P= 0.05 HS 
The hemoglobin percentage revealed a significant difference with 
16 cases ie., 41% in the 8-10 g % range, 12 cases >10 g % range and 
about 11 cases 6-8 g % group. 
Graph 7: Hemoglobin in children with malaria 
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Table 12 : WBC levels in malaria cases. 
WBC count 
(per cmm) 
Total no of 
cases 
Positive cases Percentage 
<4000 30 4 10.2 
4000-11000 99 30 76.9 
>11000 31 5 12.8 
Total 160 39 100 
 
No significant difference was found in WBC count which was 
statistically significant. 13 cases fell into 4000-11000 range. 4 cases were 
less than 4000 cells.  
Graph 8: WBC levels in malaria cases. 
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Table 13 : Monocyte counts in malaria. 
Monocyte 
count% 
Total no of 
cases 
Positive cases Percentage % 
0-3 67 14 36 
4-6 60 18 46 
7-9 33 7 18 
Total 160 39 100 
X2=1.65, P= 0.44 NS 
There was no statistical significance in the monocyte count 
between the cases of malaria. 46.2% cases had monocyte count of  
4%-6%. 
Graph 9: Monocyte counts in malaria. 
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Table 14 : Platelet counts in Malaria 
Platelet count 
(lakhs/cmm) 
Total no of 
cases 
Positive cases 
Percentage 
% 
<1.5 102 31 79 
1.5-4.5 58 8 21 
Total 160 39 100 
 
There was a statistically significant correlation between platelet 
and malaria cases. 31 cases had counts less than 1.5 lakhs, 8 cases had 
1.5-4.5 lakhs which constitute 79.5% and 20.5% respectively.  
Graph 10: Platelet count in Malaria 
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Table15 : Species of parasite by peripheral smear study 
Species No of cases Percentage % 
Pl.vivax 23 71.8 
Pl.falcipaum 9 28.2 
Total 32 100 
 
It shows 32 cases positive for plasmodium vivaxin the peripheral 
smear study. 9 case plasmodium falciparum, which mount to 71% and 
28% respectively.  
Graph 11: Species of parasite by peripheral smear study 
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Table 16 : Comparison between the 2 tests in the diagnosis of malaria 
based on species 
TEST Pl.vivax Pl.falciparum X
2 
P value 
PBS 23 9 124.1 <0.001HS 
HRP2/PLDH 26 11 149.3 <0.001HS 
 
Both the above tests reveal that plasmodium vivax are more when 
compared to plasmodium falciparum. The test was statistically 
significant. The total number of plasmodium vivax and plasmodium 
falciparum was 28 and 11 by both the above tests. 
Graph 13: Comparison between the 2 tests in the diagnosis of 
malaria based on species 
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Table 17 : Correlation of HRP2/PLDH test with peripheral blood 
smears. 
Plasmodium 
species 
HRP2/PLDH 
Result 
PBS result 
Positive Negative Total 
Pl. vivax Positive 21 5 26 
Negative 2 132 134 
Total 23 137 160 
 X2=111.2 ; P < .001 HS 
Pl. 
falciparum 
Positive 9 2 11 
Negative 0 149 149 
Total 9 151 160 
 X2=129.2 ; P<.001 HS 
 
Plasmodium vivax was positive in both the tests were 21 cases. 
The remaining 5 cases of the 26 cases positive for plasmodium vivax 
were shown by HRP2/PLDH kit test. 2 cases negative in the card test 
were shown positive by peripheral smear. Comparing the difference, it is 
proved to be statistically significant.  
Both methods similarly were positive for plasmodium falciparum 
in 9 cases. Peripheral blood smear was negative in 2 cases which were 
identified by rapid diagnostic tests. Applying statistical analysis it 
revealed to be highly significant. 
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Table 18: Correlation of Peripheral blood smears with  
HRP2/pLDH test. 
HRP2/PLDH 
Result 
PBS result 
Positive Negative Total 
Positive 30 7 37 
Negative 2 121 123 
Total 32 128 160 
 
From this comparison tables it is well understood that HRP2/PLDH 
is sensitive, specific with a percentage of 93%, 94% respectively. The 
positive predictive value, negative predictive value, and diagnostic 
efficacy was 81.1%, 98.4%, and 94.4% respectively. 
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DISCUSSION 
This study "The role of immune chromatographic antigen detection 
test assay  in  the early diagnosis of malaria" was done  in  Institute  of  
social paediatrics, Stanley medical College located in North Chennai 
area. During the study the children brought to the hospital within 12 years 
of age having fever were studied. 
          The incidence was more among children belonging to 9 to 12 year 
age group of which male children constituted 61.5% and female children 
that 38.5%. The total number of cases positive were 39 of which 24 cases 
were male children and 15 cases were female children. 
           In our study the symptoms most commonly encountered in 
children having malaria were  1) fever – 100%, 2) chills and rigors – 
52%,  3) headache – 38%   4) sweating – 15%  5) abdominal pain – 35%. 
            On systemic examination 64% children were anaemic, 89% 
children presented with enlarged spleen, 74% had liver enlargement. 
None of the cases showed features of severe malaria. 
             Anaemia – haemoglobin of     8–10 g %–41% cases, and  6–8g % 
– 28.2% cases. There is no uniform variation in the degree of anaemia. 
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            Total cell count – 4000 to 11,000 – 76%.  The total white cell 
count usually remained within the range of normal in un complicated 
malarial infection. Mild increase is noted in severe forms. 
     Platelet count :< 1.5/cubic millimetre – 79.4%. The platelet 
count decreases in acute malaria but does not lead to severe 
thrombocytopenia except in profound cases. 
Study Series Cases 
Total 
Cases 
Examined 
Positive 
Percentage 
% 
Jelinek T et al37(1999) 231 69 29.8 
Palmer CJ et al38(2003) 216 43 20 
Misra MN et al 39 (2007) 400 90 22.5 
Malik S et al40 (2004) 124 59 47.5 
Present study(2013) 160 32 20 
 
Table above. 21: Peripheral blood smear positivity in suspected 
malaria cases 
Compare rapid diagnostic test HRP2/PLDH with the peripheral blood 
smear examination.  
       Rapid diagnostic test using HRP 2/PLDH detected 37 cases to be 
positive for Plasmodium species, by the peripheral smear only 32 cases 
were detected. Seven cases of Plasmodium vivax detected by kit were not 
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detected by PBS.  This can be explained by the fact that nowadays 
practising physicians in the name of presumptive treatment give 
unjudicious use of antimalarials as well as inadequate dosing. The LDH 
enzyme produced only by viable organisms and hence negative. Another 
reason for the discrepancy can be because of low levels of enzyme 
produced by parasite in the early stage of infection. It can also be due to 
the kit unable to detect the low levels of enzyme.        
          Another discrepancy was two cases detected by peripheral blood 
smear missed by rapid diagnostic tests. This can be explained by the fact 
that since one of the two are Plasmodium falciparum it could have been 
sequestered inside the organs and hence the blood did not contain the 
organism. One case was Plasmodium vivax this could've been because 
the organism was damaged during the process are there were other cross-
reactive antibodies producing false-positive result in the rapid diagnostic 
test. 
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Table 22: Comparison  results  PBS  Study and   Hrp2/pLDH Test   
in different   studies. 
Study series 
 
Percentage of positivity 
PBS Study Hrp2/pLDH Test 
Carol J. Palmer et al41 (1998)  48% 45% 
T. Jelinik T et al37 (1999)  29.8% 24.2% 
Jamshaid Iqbal et al42 (2002)  36.1% 30.6% 
Palmer CJ et al38 (2003)  20% 19% 
Jamshaid Iqbal et al43 (2003)  42% 32% 
Chayani N et al31 (2004)  52.5% 50.8% 
Present study (2013)  20% 23.1% 
        
  In comparison of peripheral blood smear and rapid diagnostic test 
our study showed 20% in smear and 23.1% in the card to be positive. 
These values correlated well with Palmer CJ et al done on 2003 and 
Jelinek T et al in the year 1999. The others had a higher positive 
percentage as compared to our trial. 
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Table:  Sensitivity and specificity of  hrp2/ pLDH test  
for Pl.falciparum 
Study series Sensitivity Specificity 
Palmer CJ et al41 (1998)  88% 99% 
Jelinik T et al37 (1999) 88.5% 99.4% 
Jamshaid Iqbal et al42 (2002) 87% 99% 
Chayani N et al31 (2004) 88.4% 99% 
Present study (2013) 91.3% 96.3% 
 
Table 24: Sensitivity and specificity of  Hrp2/ pLDH test for Pl.vivax 
Study series Sensitivity Specificity 
 Carol J. Palmer et al41 (1998) 94% 100% 
 Jelinik T et al37 (1999)  61.5% 100% 
 Jamshaid Iqbal et al41 (2002)  79% 97% 
 Chayani N et al31 (2004)  96.8% 100% 
 Present study (2013)  100% 98.7% 
 
           Sensitivity was around 91.3% to 100% and specificity of 96.3% to 
98.7%. This was in comparison to the gold standard peripheral smear. 
The results showed positive correlation with Palmer CJ et al 
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Table 25: Positive predictive value and Negative predictive value of 
hrp2/pLDH test for Pl.falciparum malaria 
Study series  PPV NPV 
Palmer CJ et al41 (1998)  88% 99% 
Jelinik T et al37 (1999)  97.9% 96.7% 
Jamshaid Iqbal et al42 (2002) A 94% 99% 
Jamshaid Iqbal et al43 (2003)  89-97% 96-98% 
Chayani N et al31 (2004)  92% 98.5% 
Present study (2013)  80.8% 98.5% 
 
Positive predictive value of our tests is  98.5% – 100%. It was in 
comparison peripheral blood smear. The results were similar to Palmer 
CJ et al Positive predictive value of study was 80.8% to 81.8%.  
The negative predictive value was around and Jelinek et al. 
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Table 26: Positive predictive value and Negative predictive value of 
hrp2/pLDH test for Pl.vivax malaria 
 
Study series  PPV NPV 
Palmer CJ et al41 (1998)  100% 96% 
Jelinik T et al37 (1999)  100% 97.8% 
Jamshaid Iqbal et al42 (2002)  91% 93% 
Jamshaid Iqbal et al43 (2003)  88-95% 90-93% 
Chayani N et al31 (2004)  100% 97.8% 
Present study (2013)  81.8% 100% 
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CONCLUSION 
          Peripheral blood smear examination for the diagnosis of malaria is 
a time-tested accurate investigation. Till now it is considered as the gold 
standard in the identification of malaria. The reasons for this reputation 
is, it is very cheap, all the organisms can be identified, the degree of 
parasitaemia can be found with high sensitivity. The disadvantage of the 
test is it require skilled technician and is time-consuming. 
          In the study we compact the rapid diagnostic test with the 
peripheral blood smear examination and identified that is almost similar 
inefficacy to it. Sensitivity of 91.3% and 100% specificity 96.3% and 
98.7% for Plasmodium falciparum, Plasmodium vivax compared to 
peripheral smear examination. 
         An ideal test should be simple, rapid, specific, sensitive not 
requiring special equipments and requiring less technical skills. The rapid 
diagnostic test is all the above characters making it an ideal test in 
malaria diagnosis. 
           Here quality of RDT is on par with the PBS but the cost of the test 
kit is high limiting the use on a wide scale. On the short-term basis 
though it appears costly the burden of the disease due to resistant 
organisms arising as a result of our personal use of drugs seems to be 
more costly in the long run. Hence RDT helps malaria control on a long-
term basis making accurate diagnosis and accurate treatment. 
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SUMMARY 
 The study was conducted in Institute of social paediatrics on one 
stage children attending the hospital. Its aim is to identify the role 
of immune chromatographic antigen detection test in diagnosis of 
malaria. 
 Out of the 160 children, 39 children were positive for malaria by 
any of the two methods either RDT or peripheral blood smear 
 the symptomatology of these patients with malaria had fever 
universally (100%), followed by chills and rigours (51.2%), 
headache (38.5%), abdominal pain (35.9%). 
 The signs commonly observed in this set of patients with malaria 
was pallor 64%, splenomegaly 89.7%, hepatomegaly 74.3%. 
 Malaria positive by the card test – 32 cases (20%),  Malaria 
positive by peripheral blood smear – 37 cases (23.1%). 
 The Plasmodium vivax positivity in peripheral blood smear were 
23 and Plasmodium falciparum was nine cases. The total positive 
for malaria was 32 cases. 
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 The Plasmodium vivax positive in rapid diagnostic test was 26  
and Plasmodium falciparum was 11 cases. The total positive cases 
were 37. 
 The sensitivity of rapid diagnostic test was 93.8% and a specificity 
of the RDT was 93.8%. These values are correlated compared with 
the gold standard test peripheral blood smear. 
 Species-specific sensitivity of smear are Plasmodium falciparum 
sensitivity of 91% and specificity of 96%, Plasmodium vivax 
showing a sensitivity of 100% and specificity of 98.7%. 
 Positive predictive value of the rapid diagnostic test using the HRP 
2/PLDH showed falciparum to be 80.8% and vivax has 81.8%. The 
negative predictive value of Plasmodium falciparum was 98.5% 
and the same for Plasmodium vivax was 100%. 
 The rapid diagnostic test was found to be comparable with and 
reliable with the peripheral blood smear. This test can be used in 
areas where peripheral blood smear cannot be done. The main 
drawback of the test is the high cost of the test and technically it is 
difficult to identify the disease severity using their rapid diagnostic 
test. 
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PROFORMA 
ROLE OF IMMUNOCHROMATOGRAPHIC ANTIGEN  
DETECTION ASSAY IN THE EARLY  DETECTION  OF  MALARIA 
PATIENT    NAME  : 
                         AGE  : 
                        SEX    : 
                ADDRESS : 
                       IP No.  : 
             DOA&DOD  : 
                                    
 CHIEF  COMPLAINTS                          YES                    NO 
1)  FEVER 
2)  CHILLS  AND  RIGORS 
3)  HEADACHE 
4)  SWEATING 
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5)  CONVULSION 
6)  ALTERED SENSORIUM 
7)  VOMITING 
8)  PAIN  ABDOMEN 
9)  OTHERS 
VITALS 
1)  HEART RATE 
2)  RESPIRATORY  RATE 
3)  BLOOD  PRESSURE 
4)  TEMPERATURE 
ANTHROPOMETRY 
1)  WEIGHT 
2)  HEIGHT 
3)  WEIGHT  FOR  AGE 
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GENERAL   EXAMINATION 
             1) PALLOR      
2)  ICTERUS 
3)  PETECHIAE/ PURPURA 
SYSTEMIC  EXAMINATION: 
  P/A    HEPATOMEGALY—IF YES  SIZE/ CONSISTENCY 
           SPLENOMEGALY – IF YES   SIZE/ CONSISTENCY 
   CVS                                 RS                            CNS        
  LABORATORY  DATA 
 CBC 
 IMMUNOCHROMATOGRAPHIC  TEST 
 PERIPHERAL  SMEAR 
 ADDITIONAL   TESTS  AS   REQUIRED 
1)WIDAL   2)  URINE  ROUTINE   3)  MSAT   4)  URINE  
C/S 
FINAL   DIAGNOSIS: 
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KEY TO MASTER CHART 
M   - Male 
F   - Female 
OP   - Outpatient 
IP   - Inpatient 
P   - Present 
A   - Absent 
PA   - Pain Abdomen 
VO   - Vomiting 
CO   - Convulsion 
Wt   - Weight 
Ht   - Height 
Wt. for age  - Weight for age 
HR   - Heart Rate 
RR   - Respiratory rate 
BP   - Blood Pressure 
Temp.  - Temperature 
Hb%   - Hemoglobin Percentage 
TC   - Total cell count 
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DC   - Differential count 
N%   - Neutrophil percentage 
M%   - Monocyte percentage114 
L%   - Lymphocyte percentage 
Plt   - Platelet 
Pl.f   - Plasmodium falciparum 
Pl.v   - Plasmodium vivax 
F.malaria  - Falciparum malaria 
V.malaria  - Vivax malaria 
GPf   - Gametocyte of Plasmodium falciparum 
RPf   - Ringform of of Plasmodium falciparum 
LTPv  - Late Trophozoite of Plasmodium vivax 
SPv   - Schizont of Plasmodium vivax 
RPv   - Ringform of Plasmodium vivax 
V.Encephalitis – Viral Encephalitis 
+ - Positive 
- - Negative 
 

ÑΥ Ικ×Θο Σ⁄Ξλ 
ΤúΩ↔Υô ΚôµεΜο ≅°Ï°Κρ ∆ρΖ ÏΨϕûΘΚÞχÏ Φ↓Θο 
ΚηÓ♦⁄χΚχ á⁄Υ ΒςιΘ úΜôΘû∴ Øû[ Σσ° ΑςôµΘο 
 
Αςôµε′ ♣ûΩΥλ  9  ÏΨϕûΘΚρ ΜêΚ ΡΩ ΤÚιÕΞκ♦↔Ü 
 ≅ςÑ υΟôτ← ΤÚιÕΞΤû∴+ 
 ùΜτû∴ , 5// //0− 
ΣδÏ ùΣßλ úΡôΥô↓♠τ ùΣΥν 9     ΞΥÕ 
ΣδÏ ùΣßλ úΡôΥô↓♠τ Φη 9     Σô←∴λ9 Αη    ùΣη     
úΡôΥô↓♠τ ↑ΩôΜλ 9 
 
 
úΡôΥô↓ ΒΘû∴ ∋3( Ï°χΚÜλ 9 
 
 
 úΤúΩ Ï°κ♦γÓρΖ ΤÚιÕΞ Αµ↑τ ↑ΞςδΚρ Φ∴χÏ 
↑ΖχΚκΣγΟÕ− ΦτàûΟΥ ΜϕúΘΚδΚûΖ úΚγΚÜλ+ ≅ΘσΚô∴ ΘÏϕΘ 
↑ΖχΚδΚûΖ ùΣ[Üλ ΞôµκΣ↓χΚκΣγΟÕ− 
 Ρôτ Φτ ÏΨϕûΘûΥ Θτ±εûΜΥôΚΘôτ ΣδúΚσΚ 
≅àΤƒχ€ú[τ− ΦϕΘ ΚôςΠιƒ∴ôúΩô ΦϕΘ ΚγΟιƒÛλ ΦϕΘ ΜγΟ 
′χΚÛχÏλ ∆γΣΟôΤο Φτ ÏΨϕûΘûΥ ΒπΞôµ↑ο ΒÚϕÕ ↑Ωχ€χ 
ùΚôρΖΩôλ Φτß ≅°ϕÕ ùΚôηúΟτ− 
 ΒϕΘ  ΑµÜ  ΜλΣϕΘΤôΚÜλ  úΤÛλ  ΒûΘ  ΜôνϕΘ  ΑµÜ  
úΤσùΚôρÞλ úΣôÕλ ΒϕΘ Αµ↑ο ΣδÏùΣßλ ΤÚιÕΞν Φτ 
ÏΨϕûΘ♠τ ΤÚιÕΞ ≅°χûΚΚûΖ ΣôνκΣΘσÏ Φτ ≅àΤƒ 
úΘûΞ♠οûΩ Φ∴ ≅°ϕÕ ùΚôρ€ú[τ− Φτ ÏΨϕûΘûΥ Αµ↑ο 
ΒÚϕÕ ↑Ω€χ ùΚôηΟôÛλ ΒÕ ùΣôÚϕÕλ Φ∴ ≅°€ú[τ− 
 ΒϕΘ Αµ↑τ êΩλ €ûΟχÏλ ΘΚΞοΚûΖÙλ+ Σ↔úΜôΘû∴ 
Ø⁄ÜΚûΖÙλ Τσßλ ′€εûΜ ùΘôΟνΣô∴ ΘΚΞοΚûΖÙλ ΤÚιÕΞν 
úΤσùΚôρÞλ Αµ↑ο ΣΥτΣÓιƒχ ùΚôρΖÜλ ≅ûΘ ♦ςÑ↔χΚÜλ 
Φτ ØÝ Τ∴ÕΟτ ΜλΤƒχ€ú[τ− 
 ΒϕΘ Αµ↑ο ΣδÏ ùΚôρΖ Ικ×χ ùΚôρ€ú[τ− Φτ 
ÏΨϕûΘχÏ ùΚôÓχΚκΣγΟ ≅°ÜûςΚ↓τΣ⁄ ΡΟιÕ ùΚôρΞÕΟτ ΒϕΘ 
ΑµûΞ úΤσùΚôρÞλ ΤÚιÕΞ ≅∞χÏ ∆ηûΤÙΟτ ΒÚκúΣτ 
Φτßλ ∆ßƒ ≅↓χ€ú[τ− Φτ ÏΨϕûΘ♠τ ∆Οο ΡΩλ 
ΣôƒχΚκΣγΟôúΩô ≅οΩÕ ΦƒνΣôςôΘ ΞΨχΚιƒσÏ Τô[ô∴ úΡôµχÏ° 
ùΘτΣγΟôúΩô ∆Οú∴ ≅Θû∴ ΤÚιÕΞ ≅∞χÏ ùΘ↔↑κúΣτ Φ∴ 
∆ßƒ ≅↓χ€ú[τ− 
 ΒϕΘ Αµ↑ο Φτ ÏΨϕûΘχÏ ΒςιΘλ+ ′ß¿ν+ Φχυúς+ 
υúΚτ ∆γΣΟ ≅û∴ιÕ Σ↔úΜôΘû∴ΚûΖÙλ ùΜµÕ ùΚôρΖ Ρôτ 
ØÝ Τ∴ÕΟτ ΜλΤƒχ€ú[τ− 
 
ΣδúΚσΣΞ↔τ ûΚùΥôκΣλ −−−−−−−−−−−−−−−−−−−−−−− ΒΟλ −−−−−−−−−−−−−−−−−−−−−−−−− úΘƒ −−−−−−−−−−−−−−−−−−−  
ΚγûΟ ↑ςο ∋ΒϕΘ Σ⁄Ξλ Σ⁄ιÕ ΚôγΟκΣγÓ ×↔ϕÕ ûΚúςûΚ ≅↓χ€ú[τ(  
ΣδúΚσΣΞ↔τ ùΣΥν Τσßλ ↑ΩôΜλ −−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−  
ΑµΞôΖ↔τ ûΚùΥôκΣλ −−−−−−−−−−−−−−−−−−−−−− ΒΟλ −−−−−−−−−−−−−−−−−−−−−−−−−−úΘƒ −−−−−−−−−−−−−−−−−−−−−−−  
ΑµΞôΖ↔τ ùΣΥν −−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−− 
 
 
 
  
ΘΚΞο Σ⁄Ξλ 
ΤúΩ↔Υô ΚôµεΜο ≅°Ï°Κρ ∆ρΖ 
ÏΨϕûΘΚÞχÏ Φ↓Θο ΚηÓ♦⁄χΚχ á⁄Υ ΒςιΘ 
úΜôΘû∴ Øû[ Σσ° ΑςôµΘο 
 
Αςôµε′♠τ úΡôχΚØλ+ ΣΥτΚÞλ 9 
ΤúΩ↔Υô ΚôµεΜο ∆ρΖ ≅°Ï°ΚúΖôÓ Ξςχá⁄Υ ÏΨϕûΘΚÞχÏ+ 
ΞΨχΚΤôΚ Σ↔úΜôΘû∴ ùΜµΥχá⁄Υ ΒςιΘκΣ↔úΜôΘû∴ΚúΖôÓ ×ƒΥ 
Øû[♠ο ≅ƒúΞΚΤôΚ ΚηÓ♦⁄χΚχá⁄Υ ΒςιΘκ Σ↔úΜôΘû∴ûΥ úΜνιÕ 
ùΜµÕ+ Σ↔úΜôΘû∴♠τ Σ←∴ûΤûΥ ΚηΟ°Θο ≅Θτ êΩλ ↑ΥôƒûΥ 
Μ↔ ∆ΣôΚ ↑ûς↑ο ΚηÓ♦⁄ιΘ 
ΑµÜ ΡûΟØû[Κρ 9 
′€εûΜ ≅↓κΣΘσÏ ΓσΣôÓ ùΜµΘο ΒπΞôςôµε′♠τ úΡôχΚΤôÏλ− 
∆ρúΡôΥô↓ΚΖôΚ ≅οΩÕ ùΞ↓ úΡôΥô↓ΥôΚ ∆ρΖ ΤúΩ↔Υ ΚôµεΜο 
≅°Ï°Κρ ∆ρΖ ÏΨϕûΘΚρ ΒϕΘ Αςôµε′♠ο úΜνιÕχ 
ùΚôρΖκΣÓΞôνΚρ− 
≅ϕΘςδΚ ΘτûΤ 9 
∆δΚρ ÏΨϕûΘ♠τ ΤÚιÕΞ ΣƒúΞÓΚρ ♥ΚÜλ ≅ϕΘςδΚΤôΚ 
ûΞιÕχ ùΚôρΖκΣÓλ Τσßλ ♦[ ΤÚιÕΞνΚρ . ↑φΝô±Κρ . ΒϕΘ 
Αµ↑τ Θ±χûΚΥôΖνΚρ ≅οΩÕ Αςôµε′ ΑΘςΞôΖνΚ↓τ ♦ςƒ 
♣ƒΚρ Α€úΥô↔Ολ ≅ûΞ ùΞ↓κΣÓιΘκΣÓλ− ΒϕΘ Αµ↑τ Ø⁄ÜΚρ 
≅°↑Υο Σιƒ↔χûΚΚ↓ο Σ↔Ñ↔χΚκΣΟΩôλ− Α∴ôο ùΣΥûς 
ùΞ↓♠ÓΞΘτ êΩλ úΡôΥô↓♠τ ≅ûΟΥôΖλ ΚôγΟκΣΟ ΤôγΟôνΚρ− 
Αµ↑ο ∆δΚρ ΣδúΚσ× Τσßλ ∆δΚρ ∆↔ûΤΚρ 9 
ΒϕΘ Αµ↑ο ∆δΚρ ÏΨϕûΘΚ↓τ ΣδúΚσ× ØÝΞÕλ 
∆δΚÞûΟΥ ↑ÚκΣιûΘ ΜôνϕΘÕ− Βƒο ¿δΚρ ΣδúΚσΚúΞô+ ΤßχΚúΞô+ 
Σôƒ♠ο ùΞ↓úΥ↔ΟúΞô ≅οΩÕ Ï°κ♦γΟ úΚρ↑ΚÞχÏ ΣƒΩ↓χΚ 
ΤßχΚúΞô ∆δΚÞχÏ ØÝ ∆↔ûΤ ∆ηÓ ΦκΣ⁄ ΒÚϕΘôÛλ ∆δΚρ 
ÏΨϕûΘ♠τ ∆Οο ♣ûΩχúΚσΣ ∆δΚρ ÏΨϕûΘχÏ ùΣôÚιΘΤô∴ ′€εûΜ 
≅↓χΚκΣÓλ  ΘôδΚρ  ΒÕ  Ï°ιÕ  úΞß  ↑ΣςδΚρ  ùΘ↔ϕÕ  ùΚôρΖ  
↑Úλ♦∴ôο ΦδΚ↓Ολ úΚγÓι ùΘ↔ϕÕ ùΚôρΖΩôλ− 
 
úΤÛλ ↑ΣςδΚρ ≅°Υ •θχΚηΟ ΡΣûς ≅ÔΚÜλ 9 
ΤÚ−Βςô−Α∴ϕι 
ΣγΟúΤσΣ⁄κ× ΤôΠΞν  
ÏΨϕûΘΚρ ΡΩ ΤÚιÕΞλ 
≅ςÑ υΟôτ← ΤÚιÕΞ Κοí↔+ ùΜτû∴ 
ùΘôûΩκúΣ′ Φη−8//2724341 
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1 1451550 4 F P P P A A A A 74.59 P A A S 2 Soft 2.5 soft 8.70 5200 64 34 2 1 + - PL.V vivax.mal
2 1451555 7 F P P A A A A VO 90.5 A A A S 2.5 Soft 2 soft 10.00 9200 54 44 2 0.8 - - - - viral fever
3 145435 8 M P P A A P A A 74.5 P A A S 2 Soft 1.5 soft 9.00 8700 42 54 4 0.4 - - - - viral fever
4 145566 6 M P P A A A A VO 94.5 P A A S 1 firm 1.5 firm 9.80 2670 50 48 2 2 - - - - Enteric Fever
5 506856 12 M P P A P A A A 90.2 P A A S 1 Soft 2 soft 7.20 6700 58 40 2 1.2 - + PL.F PL.F Fal.malaria
6 506960 12 F P A A P A A A 75.9 P A A S 2.5 - A - 8.60 1200 45 50 5 0.3 - - - viral fever
7 145794 10 M P A A P A A A 86.5 A A A S A firm 3 firm 11.20 10200 66 27 7 3.4 - - - - Enteric Fever
8 1455293 8 F P A A P A A VO 78.5 A A A S 2 Soft 1 soft 11.90 3900 62 32 6 1.5 - - - - viral fever
9 1455202 10 F P P A P A A A 86.1 P A A S 2 Soft 3 soft 9.20 9600 56 44 0 0.96 + - - pl.v V.Malaria
10 1451696 11 F P P A P A A A 95.7 P A A S 3 Soft 2 soft 10.80 7600 46 50 4 3.2 - - - - viral fever
11 1451683 9 F P P A A P A A 86.3 A A A S 1 - A - 11.20 4200 44 51 5 1.08 - - - - Enteric Fever
12 1451643 8 M P A A P P A A 74.5 A A A S 1.5 Soft 1 soft 12.40 4800 28 70 2 1.4 - - - - Viral fever
13 1451788 4 M P A A A A A VO 84.5 P A A S 2 Soft 3 soft 8.10 13000 64 28 8 0.76 - - - - Enteric Fever
14 506797 12 F P P P P A A VA 80.2 P A A S 2 Soft 2.5 soft 6.20 7000 56 42 2 3.3 - + pl.f pl.f Fal.malaria
15 1451348 8 M P P A A A A A 78.4 A A A S 1 Soft 2 soft 12.40 11200 46 47 6 1.03 - - - - Viral fever
16 1451034 9 M P A A P A A A 92.8 P A A S A - 1 soft 9.60 3500 44 51 5 1.04 - - - - Enteric Fever
17 1452110 12 M P P A P A A A 95.4 A A A S 2 Soft A - 12.60 6700 62 33 5 1.9 - - - - Viral fever
18 1451968 9 M P A A P P A A 86.8 A A S 3 Soft 1.5 firm 10.00 9600 68 30 2 1.3 - - - - Enteric Fever
19 1451173 6 M P P A A P A A 80.2 A A S 2 Soft A - 9.6 11200 46 47 6 3.3 - - - - viral fever
20 1451531 7 M P P A A P A A 81.8 A A S 1 Soft 2.5 soft 10.6 4500 60 36 4 1.8 - + PL.F pl.f Fal.malaria
21 1451559 10 M P A A P A A A 76.9 A A S 1.5 Soft 2 soft 13 7000 56 42 2 3.3 - - - - Enteric Fever
22 1451584 6 M P P A A A A A 90.5 A A S A - 3 soft 12 8700 62 32 6 1.5 - - - - Viral fever
23 1451630 7 M P A P A P A A 81.8 A A S 1.5 Soft 2 soft 13 9500 70 28 2 1.5 - - - - viral fever
24 1451680 4 F P A A P A A VO 85.2 A A S 2 Soft A - 6.5 12300 64 34 2 3.1 - - - - Enteric Fever
25 1451663 7 F P A A P A A A 77.2 A A S 1.5 Soft 2 soft 11.5 8700 62 32 6 1.5 - - - - Viral fever
26 507227 12 M P P A A A A A 81.2 A A S A - 3 soft 9 8600 58 40 2 1.2 + - - pl.v vivax.mal
27 5072176 10 M P A A P A A A 76.2 A A S 2 Soft 1 soft 8.3 7000 56 42 2 3.3 - - - - Viral fever
28 1451850 6 M P A A P A A A 80.2 A A S 3 Soft 2 soft 7.8 10000 70 28 2 1.5 - - - - Enteric Fever
29 1452067 11 M P P A A A A A 85.6 A A S 2 Soft 2 soft 8.7 6500 62 32 6 1.5 - - - - Viral fever
30 145208 12 F P P P A A A VO 82.5 A A S 3 Soft 1 soft 12.4 7300 58 40 2 2.2 - - - - Viral fever
31 1451189 6 M P P A P A A A 80.2 A A S A - 2 soft 9.8 9200 64 34 2 3.1 - - - - Viral fever
32 507225 9 F P P A P A A VO 92.5 A A S 2 Soft 2 soft 9.9 7600 73 21 5 1.4 - + PL.F PL.F Fal.malaria
33 507219 12 F P P A P A A VO 76.5 A A S 1 Soft 2 soft 11 7000 56 42 2 3.3 - - - - Viral fever
34 1452138 7 M P A A P A A A 86.4 A A S 2 Soft 2 soft 10 11300 70 28 2 1.5 - - - - viral fever
35 14520380 5 M P P A A A A VO 84.5 A A S 3 Soft 1 soft 9.5 12100 62 32 6 1.5 - - - - viral fever
36 1452064 6 M P P A P A A A 80.2 A A S 2 Soft 1 soft 10 7600 58 40 2 2.2 - - - - Enteric Fever
37 1451642 12 F P A A P A A A 95.2 A A S A - 1 soft 9.3 3300 88 40 2 0.5 - + GPF GPF Fal.malaria
38 1451645 4 M P A A A P A VO 74.5 A A S 3 Soft 2 soft 7.5 7000 56 42 2 3.3 - - - - viral fever
39 1451660 12 F P A A P A A A 76.9 A A S 3 Soft 2 firm 10 5400 80 18 2 1 - - - - Enteric Fever
40 1451715 11 F P P A P P A A 94.6 A A S 2 Soft 1 soft 12 3600 62 32 6 1.5 - - - - Viral fever
41 1451775 10 M P P A P A A A 86.5 A A S A - A - 9.5 10900 64 34 2 3.1 - - - - viral fever
42 507027 12 M P P A A A A VO 81.2 A A S 2 Soft 3 soft 8 9200 40 54 6 2.5 + - - PLV vivax.mal
43 1452382 5 F P P A A A A VO 82.5 A A S 2 Soft 2 soft 10 7000 56 42 2 3.3 - - - - Enteric Fever
44 1452418 12 F P P A A A A A 76.2 A A S 2 Soft A - 11 11200 62 32 6 1.5 - - - - Viral fever
45 507016 3 M P A A P A A VO 78.6 A A S 3 Soft 1 soft 12 5900 80 18 2 1 - - - - Viral fever
46 507086 8 F P P A A A A VO 78.4 A A S 2 Soft A - 9 9900 64 34 2 3.1 - - - - viral fever
47 1452554 12 M P P A P A A A 75.5 A A S 2 Soft 1 soft 12 8400 70 28 2 1.5 - - - - Enteric Fever
48 507033 10 M P A A P P A A 86.5 A A S 1 Soft 2 soft 7 3300 48 43 9 0.7 + - - PV vivax.mal
49 1452565 4 F P A A A P A VO 74.2 A A S 4 Soft 2 soft 10 7000 56 42 2 3.3 - - - - Viral Fever
50 507004 7 F P A A A A A A 85.2 A A S A - 1 soft 7 10300 62 32 6 1.5 - - - - Viral Fever
51 1451850 12 M P A A A A A A 75.2 A A S 2 Soft 2 soft 12 13500 58 40 2 2.2 - - - - Enteric Fever
52 1452587 6 F P A A A A A A 80.2 A A S 3 Soft A - 10 4700 64 34 2 3.1 - - - - Viral Fever
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53 1452626 12 M P A A A A A A 95.2 A A S 1 Soft 1 soft 9.9 10300 70 28 2 1.5 - - - - Enteric Fever
54 1452625 12 M P P A A A A A 76.5 A A S 1 Soft 1 soft 8 4900 82 11 7 1.4 - + PL.F PL.F Fal.malaria
55 507077 6 F P A A A A A A 78.2 A A S 2 Soft A - 10 11300 62 32 6 1.5 - - - - Viral Fever
56 1452635 9 F P A A A A A A 89.26 A A S 1 Soft A - 12 5500 43 51 6 1.5 - - - - Enteric Fever
57 1452638 4 M P A A A A A A 78.26 A A S 1 Soft 1 soft 11 7000 56 42 2 3.3 - - - - Viral Fever
58 507179 7 F P A A P A A A 84.2 A A S 3 Soft 2 soft 9 4500 58 40 2 2.2 - - - - viral fever
59 507036 6 M P A A A A A A 82.6 A A S 3 Soft 2 firm 10 9900 43 51 6 1.5 - - - - Enteric Fever
60 1452888 8 F P A A A A A A 80.6 A A S A - 2 soft 10 10500 70 28 2 1.5 - - - - Viral Fever
61 1452594 12 M P P A A A A A 95.2 A A S A - 1 soft 9 4300 62 32 6 1.5 - - - - Viral Fever
62 1452878 9 M P A A P A A A 89.2 A A S 2 Soft 3 soft 11 6700 32 64 4 1.2 + - - PV vivax.mal
63 507080 12 M P A A A A A A 95.6 A A S 2 Soft 2 soft 8 7000 56 42 2 3.3 - - - - Viral fever
64 1459264 6 F P A A P A A A 82.2 A A S A - 1 firm 12 6500 64 34 2 3.1 - - - - Viral Fever
65 1453003 8 M P A A A A A A 82.4 A A S 2 Soft 1 soft 10 7700 43 51 6 1.5 - - - - Enteric Fever
66 1453111 7 F P P A A P A A 81.2 A A S A - 1 soft 9 8800 62 32 6 1.5 - - - - Viral Fever
67 507096 11 F P A A A A A A 75.4 A A S A - 1 soft 8 11300 58 40 2 2.2 - - - - Enteric Fever
68 1453249 12 M P P P A A A A 74.4 A A S 2 Soft 3 firm 10 6900 32 64 4 1.06 + - - PV vivax.mal
69 1453399 8 M P A A A A A A 90.5 A A S A - 1 soft 8 6500 64 34 2 3.1 - - - - Viral fever
70 1453436 11 M P A A A A A A 70.4 A A S 2 Soft 1 soft 11 7000 56 42 2 3.3 - - - - Viral Fever
71 1453478 7 M P A A P A A A 84.2 A A S 3 Soft 1 soft 9.5 8300 62 32 6 1.5 - - - - Viral Fever
72 1452934 8 F P A A A A A A 82.6 A A S 2 Soft 2 soft 8.4 4900 62 32 6 1.5 - - - - Viral Fever
73 1453602 7 M P A A A A A A 84.2 A A S 3 Soft 1 soft 10 7900 70 28 2 1.5 - - - - Enteric Fever
74 1455630 10 F P P A A A A A 78.4 A A S 2 Soft 2 soft 10.6 7000 56 42 2 3.3 - - - - Viral Fever
75 507661 10 M P A A P P A A 80 A A S 3 Soft 3 soft 11.2 9700 60 36 4 1.16 - + PL.F PL.F Fal Malaria
76 507313 9 F P A A A A A A 82.1 A A S 2 Soft A - 9.9 9900 62 32 6 1.5 - - - - Viral Fever
77 1455253 9 M P A A A A A A 82.5 A A S 3 Soft 1 soft 10 8400 64 34 2 3.1 - - - - Enteric Fever
78 1453438 6 F P A A A A A A 83.4 A A S 2 Soft 2 soft 11 11300 70 28 2 1.5 - - - - Viral Fever
79 1455808 8 M P A A A A A A 82.6 A A S 1 Soft 2 soft 11 7000 56 42 2 3.3 - - - - Viral Fever
80 507271 10 M P A P A A A A 74.6 A A S 2 Soft A - 10 10900 62 32 6 1.5 - - - - Viral Fever
81 1453825 8 M P P A A P A A 85.2 A A S 2 Soft 2 soft 9 6900 40 56 4 1.35 - + PL.F PL.F Fal Malaria
82 507799 9 F P A A A A A A 92.5 A A S 3 Soft 1 soft 11 7000 56 42 2 3.3 - - - - Viral Fever
83 1453862 12 F P A A A A A A 74.4 A A S 3 Soft A - 10 7500 58 40 2 2.2 - - - - Viral Fever
84 507157 8 M P A A A A A A 78.4 A A S A - A firm 11 8900 70 28 2 1.5 - - - - Viral Fever
85 1451209 10 M P P A P A A A 76.9 A A S 2 Soft 2 soft 10 6700 36 58 4 1.3 + - - PV vivax.mal
86 1455864 6 F P A A A A A A 83.2 A A S A - A - 7 7000 56 42 2 3.3 - - - - Viral fever
87 507064 10 F P A A A A A A 78.4 A A S 3 Soft 1 soft 11 5500 62 32 6 1.5 - - - - Viral Fever
88 1453876 4 M P A A A A A A 71.2 A A S 2 Soft 2 soft 11 8800 64 34 2 3.1 - - - - Enteric Fever
89 1453859 8 M P P P A A A A 82.6 A A S 2 Soft 3 soft 10 9650 42 56 2 1.06 + - - PV vivax.mal
90 1453718 9 F P A A A A A A 75.2 A A S 2 Soft 3 soft 10 7000 56 42 2 3.3 - - - - Viral Fever
91 1453995 10 M P A A A A A A 73.5 A A S 3 Soft 1 firm 10 9400 43 51 6 1.5 - - - - Viral fever
92 1454036 10 M P P A A A A A 76.9 A A S 1 Soft 2 soft 7.2 8300 62 32 6 1.5 - - - - Viral Fever
93 1454043 8 M P A A P P A A 78.4 A A S A - 1 soft 9.5 9800 42 54 4 0.7 + - - PV vivax.mal
94 1454088 9 M P A A A A A A 82.1 A A S 3 Soft 1 soft 8.4 7700 73 20 7 2.2 - - - - Viral Fever
95 507363 12 M P P P A A A VO 94.5 A A S 2 Soft 2 soft 10 4200 28 64 8 1.03 + - - PV vivax.mal
96 1455862 10 F P A A A A A A 80 A A S A - 1 soft 10.4 7000 56 42 2 3.3 - - - - Enteric Fever
97 1454138 8 F P A A A A A A 86.5 A A S 2 Soft 2 soft 11.4 9500 62 32 6 1.5 - - - - Viral fever
98 1454153 7 M P A A A A A A 81.5 A A S 1 Soft 3 firm 7.4 5900 70 28 2 1.5 - - - - Viral Fever
99 1454286 12 M P P P A A A A 74.2 A A S 1 Soft A - 8.4 6400 28 64 8 0.7 + - - PV vivax.mal
100 501373 9 F P P A A P A A 92.8 A A S 1 Soft 2 soft 10.4 6500 64 34 2 3.1 - + PL.F PL.F Fal Malaria
101 1454296 8 M P A A A A A A 78.2 A A S 1 Soft 1.5 soft 11.3 7000 56 42 2 3.3 + - - PV vivax.mal
102 507338 7 M P A A A A A A 85.6 A A S A - 2 firm 12 6800 58 40 2 2.2 - - - - Enteric Fever
103 1454368 10 M P A A A A A A 74.6 A A S 1.5 Soft 2 soft 7 5500 43 51 6 1.5 - - - - Viral Fever
104 1454322 11 M P A A A A A A 95.4 A A S A - 1 soft 10 12300 62 32 6 1.5 - - - - Viral Fever
105 507330 10 M P A A P A A A 86.5 A A S 1.5 Soft 1 soft 9.5 7000 56 42 2 3.3 - - - - Viral Fever
106 1454570 12 F P A A A A A A 82.5 A A S A - 2 soft 9.5 11300 64 34 2 3.1 - - - - Viral Fever
107 1454552 9 M P A A A A A A 86.3 A A S 2.5 Soft 1 soft 8.4 10000 70 28 2 1.5 - - - - Enteric Fever
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108 1454564 11 M P A A A A A A 95.4 A A S 1 Soft 3 soft 9.3 9100 62 32 6 1.5 - - - - Viral Fever
109 11454695 9 F P P A A A A VO 76.2 A A S A - 3 soft 10.2 4500 62 32 6 1.09 + - - PV vivax.mal
110 1454365 12 M P A A A A A A 85.4 A A S A - A - 10 7000 56 42 2 3.3 - - - - Viral Fever
111 507397 9 F P P A A A A A 86.3 A A S 2 Soft 2 soft 8.2 7800 46 50 4 2.6 + - - PV vivax.mal
112 507359 7 F P A A A A A A 81.8 A A S 2.5 Soft A - 8.4 9200 56 42 2 3.3 - - - - Viral Fever
113 1454753 10 F P A A A P A A 76.2 A A S A - A - 9.5 7000 56 42 2 3.3 - - - - Viral Fever
114 1454738 11 M P A A A A A A 85.2 A A S 1.5 Soft A - 8.6 8300 73 20 7 2.2 - - - - Viral Fever
115 1438380 7 M P A P A A A A 77.2 A A S 1 Soft 3 firm 9.9 7400 62 32 6 1.5 - - - - Enteric Fever
116 1454762 8 F P A A P A A A 74.5 A A S 2 Soft A - 10 6500 58 40 2 2.2 - - - - Viral Fever
117 1454773 6 M P A A A A A A 80.2 A A S A - 3.5 soft 7 7000 56 42 2 3.3 - - - - Viral Fever
118 1454537 12 F P P A A A A A 81.2 A A S 2 Soft 2 soft 9.8 7400 64 34 2 3.1 - - - - Viral Fever
119 507402 12 F P A A P A A A 85.4 A A S 1.5 Soft 3.5 soft 9 27000 60 37 3 1.54 + - - PV vivax.mal
120 1457083 10 M P P A A A A A 86.2 A A S A - 1.5 soft 10.4 8400 70 28 2 1.5 - - - - Viral Fever
121 1455768 11 M P A A A P A A 86.4 A A S 2 Soft 2 soft 8 4500 46 50 4 1.02 + - - PV vivax.mal
122 145642 9 F P A A A A A A 86.3 A A S A - 3 soft 11.3 7000 56 42 2 3.3 - - - - Enteric Fever
123 1455425 8 F P P A A A A VO 76.2 A A S 2.5 Soft A - 12 6200 78 22 0 0.46 + - - PV vivax.mal
124 1455115 12 F P A A A A A A 86.2 A A S 2.5 Soft 3 soft 7 9100 62 32 6 1.5 - - - - Viral Fever
125 1483063 4 M P A A P A A A 88.6 A A S 1.5 Soft 1 soft 10 11200 58 40 2 1.45 + - - PV vivax.mal
126 145001 12 M P A A A A A A 75.6 A A S A - A - 12 7000 56 42 2 3.3 - - - - Viral Fever
127 1454867 8 F P A A A A A A 74.5 A A S 3 Soft 2 soft 11.3 3300 43 51 6 1.5 - - - - Viral Fever
128 1454817 9 M P A A A P A A 86.3 A A S 1.5 Soft 2.5 soft 9.8 8600 44 48 3 2.4 - + PL.F PL.F Fal Malaria
129 1458337 12 F P A A A A A A 84.2 A A S 2 Soft 2 firm 8.5 11900 70 28 2 1.5 - - - - Enteric Fever
130 1453996 9 M P A A A P A A 86.3 A A S 1.5 Soft A - 8 12500 55 39 6 1.4 + - - PV vivax.mal
131 1483830 6 M P A A A A A VO 80.4 A A S A - 2 soft 12 4500 30 68 2 1.2 + - - PV vivax.mal
132 145577 7 F P P P A A A A 90.9 A A S 2 Soft 1 soft 13 8600 62 32 6 1.5 - - - - Viral Fever
133 145650 10 M P A A A P A A 76.2 A A S A - 3 firm 10.2 7000 56 42 2 3.3 - - - - Enteric Fever
134 1455424 9 M P A A A A A A 86.36 A A S 1.5 Soft 3 soft 9.4 6700 64 34 2 3.1 - - - - Viral Fever
135 145010 10 F P P A A A A VO 76.4 A A S 1 Soft 3 soft 9.4 10000 60 36 4 1.14 + - - PV vivax.mal
136 1454853 6 M P A A A P A A 80.2 A A S 2 Soft A - 8.5 8300 73 20 7 2.2 - - - - Viral Fever
137 1454547 5 M P A A A A A A 94.5 A A S 1 Soft 3 soft 9.1 9400 42 57 7 1.2 + - - PV vivax.mal
138 1453106 10 F P A A P A A A 76.2 A A S 2 Soft 2.5 soft 8.7 7500 62 32 6 1.5 - - - - Viral Fever
139 1483839 12 F P A A A P A A 84.2 A A S 1 Soft 1.5 soft 10 9400 46 47 6 1.2 + - - PV vivax.mal
140 1483849 8 M P P A A A A A 78.2 A A S 3 Soft 2.5 firm 10.5 7000 56 42 2 3.3 - - - - Enteric Fever
141 1455167 7 F P A A A A A A 90.9 A A S 2 Soft 1 soft 12 6300 58 40 2 2.2 - - - - Viral Fever
142 145640 10 M P A P A A A A 84.2 A A S 3 Soft 1 soft 8.7 5300 70 28 2 1.5 - - - - Viral Fever
143 1455424 11 F P A A A A A VO 95.7 A A S 1 Soft 2 soft 12 7000 56 42 2 3.3 + - - PV vivax.mal
144 1455414 9 M P A A A A A A 86.3 A A S 1.5 Soft A - 9 4300 62 32 6 1.5 + - - - Viral Fever
145 1455062 6 M P P A A A A A 80.4 A A S A - 3 soft 10.2 1800 58 40 2 1.39 + - - PV vivax.mal
146 145000 12 F P A A A A A A 75.9 A A S 3 Soft A - 10 9400 64 34 2 3.1 - - - - Viral Fever
147 1454866 11 M P A A P A A A 95.7 A A S 1 Soft 2.5 soft 11 8500 70 28 2 1.5 - - - - Enteric Fever
148 1454843 10 M P A A A A A A 85.6 A A S 2 Soft 3 soft 9 7000 56 42 2 3.3 - - - - Viral Fever
149 1454737 8 M P A A P A A VO 78.6 A A S A - 1 soft 6.5 11800 46 47 6 0.45 + - - PV vivax.mal
150 1454537 7 F P A A A A A A 90.6 A A S 2.5 Soft 1 soft 12 7400 62 32 6 1.5 - - - - Viral Malaria
151 1454366 10 F P A A A A A A 84.2 A A S 2 Soft A - 13 6400 43 51 6 1.5 - - - - Enteric Fever
152 1454996 9 F P A A A A A A 86.4 A A S 1 Soft 2.5 soft 10.5 7000 56 42 2 3.3 - - - - Viral Fever
153 1483819 6 M P P P P A A A 87.5 A A S 2.5 Soft 2 soft 10 5400 58 40 2 2.2 - - - - Viral Fever
154 1453840 12 F P A A A P A A 86.4 A A S A - A - 11.5 10200 45 50 5 0.3 - + PL.F PL.F Fal Malaria
155 145021 11 M P A A A A A A 95.2 A A S 2 Soft 1.5 soft 12 4400 64 34 2 3.1 - - - - Viral Fever
156 1454863 12 M P A A A A A A 91.2 A A S 3 Soft 2 soft 10.1 8765 70 28 2 1.5 - - - - Viral Fever
157 1454176 10 F P A A A A A A 86.5 A A S 2 Soft A - 9.4 7000 56 42 2 3.3 - - - - Viral Fever
158 1083848 9 M P P A A A A A 78.5 A A S 1.5 Soft A - 8.7 6654 62 32 6 1.5 - - - - Viral Malaria
159 1458369 8 M P A A P P A A 95.4 A A S 2 Soft 1 soft 9 6200 68 60 2 2.5 + - - PV vivax.mal
160 1458346 11 M P A A A A A A 73.2 A A S A - 1 soft 8 7000 56 42 2 3.3 - - - - Viral Fever
